UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )

Filed by the Registrant ☐

Filed by a Party other than the Registrant ☐

Check the appropriate box:

International Battery Metals Ltd.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD
ON NOVEMBER 20, 2026

MANAGEMENT INFORMATION CIRCULAR

International Battery Metals Ltd.

12 Greenway Plaza, Suite 1100

Houston, Texas 77046

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

To Be Held on November 20, 2026

Dear Shareholder:

You are cordially invited to attend the 2026 Annual General and Special Meeting of Shareholders (the “Annual Meeting”) of International Battery Metals Ltd., a British Columbia corporation (the “Company”). The meeting will be held on Wednesday, November 20, 2026 at 1:00 p.m. central time in-person at the Company’s headquarters located at 12 Greenway Plaza, Suite 1100. Houston, Texas 77046, for the following purposes:

The Annual Meeting of shareholders will be held in person. Registered holders can vote their shares in advance of the meeting by Internet, toll-free telephone, or mail. If your common shares are held in the name of a broker, bank or other holder of record, follow the voting instructions you receive from the holder of record describing how to vote your common shares. Shareholders may also vote in person at the meeting.

Our Board unanimously recommends that you vote “For” each of the proposal and “For” the election of each of the five nominees for director.

The record date for the Annual Meeting is September 22, 2026. Only shareholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. Your vote is very important. Pursuant to the rules promulgated by the U.S. Securities and Exchange Commission (the “SEC”) as permitted pursuant to National Instrument 51-102 – Continuous Disclosure Obligations and National Instrument 54-101 – Communication with Beneficial Owners of Securities of a Reporting Issuer (collectively, the “Notice and Access Provisions”) promulgated by the Canadian Securities Authorities (the “CSA”). Pursuant to the Notice and Access Provisions, we are providing access to our proxy materials, including the Notice of Annual Meeting of Shareholders (the “Notice”) by sending you this Notice and making copies of these proxy materials available on the internet. We urge you to access and review the proxy materials before voting and vote as soon as possible,

whether or not you plan to attend the Annual Meeting. This Notice is not a form for voting and presents only an overview of the more complete proxy materials, which contain important information and are available on the Internet or by mail. You will need the control number printed on your Notice, proxy card or voting instruction card in order to vote and you will not otherwise receive a paper or email copy. A list of shareholders of record will be available during the Annual Meeting for inspection by shareholders for any legally valid purpose relating to the Annual Meeting.

We are furnishing the proxy materials to our shareholders over the Internet in accordance with the Notice and Access Provisions. You may read, print and download the proxy materials at www.ibatterymetals.com/investors. On or about October [9], 2026, we will mail our shareholders the Notice containing instructions on how to access our proxy materials and vote online. The Notice also provides instructions on how you can request proxy materials be sent to you by mail and how you can enroll to receive proxy materials by mail for future meetings. Shareholders with questions about notice-and-access can call toll free at 1-866-964-0492. Shareholders may obtain paper copies of the Information Circular/Proxy Statement and any other proxy materials free of charge. Shareholders with a 15 digit control number wishing to obtain a paper copy of the Information Circular/Proxy Statement and any other proxy materials can call toll free within North America - 1-866-962-0498 or direct, from Outside of North America - (514) 982-8716 and entering your control number as indicated on your voting instruction form or proxy. Shareholders with a 16 digit control number can call toll free within North America - 1-877-907-7643 or direct, from Outside of North America - 1-303-562-9305 and entering your control number as indicated on your voting instruction form. Any shareholder wishing to obtain a paper copy of the proxy materials should submit their request no later than 5:00 PM (CST) on November 10, 2026, in order to receive paper copies of the proxy materials in time to vote before the Annual Meeting. Under the Notice-and-Access Provisions, proxy materials will be available for viewing on the Company’s website for one year from the date of posting. Shareholders wishing to obtain paper copies of the proxy materials after the Annual Meeting date can call (832) 683-8839.

Important Notice Regarding the Availability of Proxy Materials for the Shareholders’ Annual Meeting to Be Held on November 20, 2026 at 1:00 p.m. central time at the Company’s headquarters located at 12 Greenway Plaza, Suite 1100, Houston, Texas 77046, at: www.ibatterymetals.com/investors.

This Notice and Information Circular/Proxy Statement are available at www.ibatterymetals.com/investors.

By Order of the Board of Directors

James Garrett Galloway

Interim Chief Executive Officer and Senior Vice President of Corporate Development

October [9], 2026

TABLE OF CONTENTS

International Battery Metals Ltd.

12 Greenway Plaza, Suite 1100

Houston, Texas 77046

October [9], 2026

MANAGEMENT INFORMATION CIRCULAR AND PROXY STATEMENT

Management Information Circular and Proxy Statement for 2026 and Special Meeting of Shareholders

This management information circular and proxy statement, including all schedules and appendices hereto (this “Information Circular/Proxy Statement”), is being furnished in connection with the solicitation of proxies by or on behalf of management (“Management”) of International Battery Metals Ltd. (the “Company” or “IBAT”) for use at the annual general and special meeting (the “Annual Meeting”) of the shareholders of the Company to be held at the Company’s headquarters located at 12 Greenway Plaza, Suite 1100, Houston, Texas 77046, on Wednesday, November 20, 2026 at 1:00 p.m. central time, or at any adjournment(s) or postponement(s) thereof, for the purposes set out in the accompanying Notice of Annual and Special Meeting of Shareholders.

We expect that the solicitation of proxies will be primarily by mail and over the Internet. Proxies may also be solicited personally, by telephone, e-mail, Internet, facsimile or other means of communication by directors, officers and employees of the Company. Directors, officers and employees will not be additionally compensated, but may be reimbursed for out-of-pocket expenses in connection with solicitation. The cost of solicitation will be borne by the Company. Arrangements also will be made with brokerage houses and other custodians, nominees and fiduciaries for the forwarding of solicitation material to beneficial owners holding our shares in street name, and we will reimburse custodians, nominees and fiduciaries for reasonable out-of-pocket expenses in connection with the forwarding of solicitation material.

This Information Circular/Proxy Statement is accompanied by a form of proxy or a voting instruction form. By use of a proxy or a voting instruction form, you can vote even if you do not attend the Annual Meeting. The persons named in the enclosed form of proxy represent Management of the Company. Each shareholder has the right to appoint a person (who need not be a shareholder), other than those Management nominees named in the enclosed form of proxy, to represent, attend and act on behalf of the shareholder at the Annual Meeting. That right may be exercised by inserting the name of such person in the blank space provided for that purpose.

In this Information Circular/Proxy Statement, the words “IBAT,” “we,” “our,” “ours” and “us” refer to International Battery Metals Ltd. Except as otherwise stated, the information contained herein is given as of September 22, 2026. Unless otherwise indicated, all references to “$” or “dollars” are to the currency of the United States and “C$” or “CAD$” are to the currency of Canada.

NOTICE-AND-ACCESS

The Company is sending out proxy-related materials to Shareholders using the notice-and-access provisions under rules adopted by the United States Securities and Exchange Commission (the “SEC”) as permitted pursuant to National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”) and NI 54-101 (collectively, the “Notice-and-Access Provisions”) promulgated by the Canadian Securities Authorities (the “CSA”). The Company anticipates that use of the Notice-and-Access Provisions will benefit the Company by reducing the postage and material costs associated with the printing and mailing of the proxy-related materials and will additionally reduce the environmental impact of such actions.

Shareholders will be provided with electronic access to the Notice of Meeting and this Information Circular/Proxy Statement on the Company’s website at www.ibatterymetals.com/investors. They can also be found on the Electronic Data Gathering, Analysis, and Retrieval system (“EDGAR”) at www.sec.gov and the System for Electronic Document Analysis and Retrieval (“SEDAR+”) at www.sedarplus.com.

Shareholders are reminded to review the Information Circular/Proxy Statement before voting. On or about October [9], 2026, we will begin mailing to Shareholders paper copies of a Notice of Internet Availability of Proxy Materials containing information prescribed by the Notice-and-Access Provisions, including instructions on how to access and review proxy materials as well as directions on how to vote by proxy. The Company will not use procedures known as ‘stratification’ in relation to the use of Notice-and-Access Provisions. Stratification occurs when an issuer using Notice-and-Access Provisions sends a paper copy of the Information Circular/Proxy Statement to some securityholders with a notice package.

Shareholders with questions about notice-and-access can call toll free at 1-866-964-0492. Shareholders may obtain paper copies of the Information Circular/Proxy Statement free of charge. Shareholders with a 15 digit control number wishing to obtain a paper copy of the Information Circular/Proxy Statement can call toll free within North America - 1-866-962-0498 or direct, from Outside of North America - (514) 982-8716 and entering your control number as indicated on your voting instruction form or proxy. Shareholders with a 16 digit control number can call toll free within North America - 1-877-907-7643 or direct, from Outside of North America - 1-303-562-9305 and entering your control number as indicated on your voting instruction form or proxy. Any Shareholder wishing to obtain a paper copy of the Meeting materials should submit their request no later than 5:00pm (CST) on December 5, 2025, in order to receive paper copies of the Meeting materials in time to vote before the Meeting. Under the Notice-and-Access Provisions, materials for the Annual Meeting will be available for viewing on the Company’s website for one year from the date of posting. To obtain paper copies of the materials after the Annual Meeting date, please contact (832) 683-8839.

The date of this Information Circular/Proxy Statement is October [9], 2026. The Notice was first mailed to our Shareholders of record entitled to vote at the Annual Meeting on or about October [9], 2026

QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING

Why did I receive these proxy materials?

Pursuant to rules adopted by the SEC, we have made these materials available to you over the internet because the Board of Directors (sometimes referred to as the “Board”) of International Battery Metals Ltd. (sometimes referred to as “we,” “us,” the “Company” or “IBAT”) is soliciting your proxy to vote at our 2026 Annual Meeting of Shareholders (“Annual Meeting”), including at any adjournments or postponements of the meeting. All shareholders will have the ability to access the proxy materials on the website referred to in the Notice. The Notice was first mailed to our Shareholders of record entitled to vote at the Annual Meeting on or about October [9], 2026.

How do I attend the Annual Meeting?

The Annual Meeting will be held on Tuesday, November 20, 2026 at 1:00 p.m. central time at the Company’s headquarters located at 12 Greenway Plaza, Suite 1100, Houston, Texas 77046. Record holders and beneficial owners are welcome to attend the meeting, however, only record holders and beneficial owners who have obtained a legal proxy of the Company’s common shares or their proxies may vote in person at the Annual Meeting. To attend the Annual Meeting in person, you must present photo identification, such as a driver’s license. Beneficial owners must also provide evidence of stock holdings, such as a recent brokerage account or bank statement.

Who can vote at the Annual Meeting?

Only shareholders of record at the close of business on September 22, 2026 (the “Record Date”) will be entitled to vote in person or by proxy at the Meeting or any adjournment thereof. As of the Record Date, there were 296,803,677 common shares of the Company (“Common Shares”) outstanding and entitled to vote.

Shareholders of Record: Shares Registered in Your Name

If on the Record Date your shares were registered directly in your name with the Company’s transfer agent, Computershare, then you are a shareholder of record. As a shareholder of record, you may vote in person at the Annual Meeting or vote by proxy via the telephone, Internet or by mail. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted.

Beneficial Owner: Shares Registered in the Name of a Broker or Bank

If on the Record Date your shares were not held in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in “street name” and will have received a Notice from that organization. The organization holding your account is considered to be the shareholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, since you are not the shareholder of record, you may not vote your shares at the meeting unless you request and obtain a valid proxy from your broker or other agent.

What am I voting on?

There are eight matters scheduled for a vote:

How does the Board recommend I vote for each proposal

What if another matter is properly brought before the meeting?

The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the proxy to vote on those matters in accordance with their best judgment.

How do I vote?

Shareholders of Record: Shares Registered in Your Name

If you are a shareholder of record, you may vote by attending the Annual Meeting, by proxy over the telephone, by proxy through the internet, or by proxy using a proxy card that you may request. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote if you have already voted by proxy.

Beneficial Owners: Shares Registered in the Name of Broker or Bank

If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice containing voting instructions from that organization rather than from IBAT. Simply follow the instructions in the Notice to ensure that your vote is counted. To vote in-person during the meeting, you must submit a valid legal proxy via email to service@computershare.com with the subject line “Legal Proxy” by 5:00 p.m., Central Time, on October [9], 2026. If you have a valid legal proxy, you may submit your vote in-person at any time prior to the closing of the polls during the Annual Meeting.

How many votes do I have?

On each matter to be voted upon, you have one vote for each common share you own as of the Record Date, with no shares having cumulative voting rights.

What if I return a proxy card or otherwise vote but do not make specific choices?

If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, “For” the setting of the number of directors, “For” the election of all five nominees for director, "For" ratification of the selection by the Audit Committee of the Board of Grant Thornton LLP as the independent registered public accounting firm of the Company for its fiscal year ending March 31, 2027 and authorizing the directors to fix the remuneration of the auditors, “For” the Consolidation Resolution, "For" the Amendment Resolution, "For" the Continuance Resolution, and “For” authorizing the directors to fix the number of directors. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.

What are “broker non-votes”?

As discussed above, when a beneficial owner of shares held in “street name” by a US nominee does not give instructions to the broker or nominee holding the shares as to how to vote on matters deemed to be non-routine under applicable rules, the broker or nominee may not vote the shares. These unvoted shares are counted as “broker non-votes.”

Proposals 1, 2, 4(a), 4(b), 5 and 6 are considered non-routine, so a US broker or nominee holding shares may not vote those shares on Proposals 1, 2, 4(a), 4(b), 5 and 6 without specific instructions from the beneficial owner. Proposals 3 and 7, the Consolidation Resolution and the proposal to appoint auditors and authorize the directors to fix the remuneration of the auditors is considered routine and therefore, a broker or nominee located in the US holding shares may vote those shares on Proposals 3 and 7 without specific instructions from the beneficial owner.

What happens if I do not vote?

Shareholders of Record: Shares Registered in Your Name

If you are a shareholder of record and do not vote by completing a proxy card, by telephone, or through the internet at the Annual Meeting, your shares will not be voted.

Beneficial Owners: Shares Registered in the Name of Broker or Bank

If you are a beneficial owner and do not instruct your broker, bank or other agent how to vote your shares, the question of whether your broker or nominee will still be able to vote your shares depends on the jurisdiction of your broker and whether the particular proposal is considered to be a routine matter under applicable rules. If your broker is not located in the United States, your shares will not be voted. Brokers and nominees located in the United States can use their discretion to vote uninstructed shares with respect to matters that are considered to be routine under applicable rules, but not with respect to non-routine matters. Under applicable rules and interpretations, non-routine matters are matters that may substantially affect the rights or privileges of shareholders, such as mergers, shareholder proposals, elections of directors (even if not contested), executive compensation and certain corporate governance proposals, even if management-supported. Routine matters, on which a broker or other nominee is generally empowered to vote, include ratification of the appointment of an independent registered public accounting firm. Accordingly, your broker or nominee may not vote your shares on Proposals 1-6 without your instructions, but may vote your shares on Proposal 7.

What if I return a proxy card or otherwise vote but do not make specific choices?

If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, “For” the setting of the number of directors, “For” the election of each of the five nominees for director, "For" ratification of the selection by the Audit Committee of the Board of Grant Thornton LLP as the independent registered public accounting firm of the Company for its fiscal year ending March 31, 2027 and authorizing the directors to fix the remuneration of the auditors, “For” the Consolidation Resolution, "For" the Amendment Resolution, "For" the Continuance Resolution, and “For” authorizing the directors to fix the number of directors. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.

What does it mean if I receive more than one set of proxy materials?

If you receive more than one set of proxy materials, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each of the proxy cards in the proxy materials to ensure that all of your shares are voted.

Can I change my vote after submitting my proxy?

Yes. You can revoke your proxy at any time before the final vote at the meeting.

Shareholders of Record: Shares Registered in Your Name

If you are the record holder of your shares, you may revoke your proxy in any one of the following ways:

Parkway, Suite 240, Plano, Texas 75024.

Your most current proxy card or telephone or internet proxy is the one that is counted.

Beneficial Owners: Shares Registered in the Name of Broker or Bank

If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank in order to change your vote.

What are my voting options?

As set forth in the table below, you have the option to vote “FOR” and “AGAINST” or “FOR” and “WITHOLD” on the proposals. If you do not mark a vote on any specific proposal, your shares will not be voted and will have no impact on the outcome of the proposal, but will be counted as a vote present for purposes of establishing a quorum.

How are votes counted?

If you vote “For” or “Against” on any proposals your vote will be cast accordingly. Your “Withhold” vote for
Proposals 1, 3, 4(a) and 4(b), 5, 6 and 7 will be the equivalent of an abstention, will not be counted as a vote cast and will not
impact whether any of such proposals is approved. “Withhold” votes and abstentions will be counted for purposes of
determining a quorum.

How many votes are needed to approve each proposal?

* If at least a majority of the votes cast vote “FOR” the Consolidation Resolution then the Consolidation can be effected
for so long as the Company is organized under the jurisdiction of British Columbia. If at least 66⅔% of the votes cast
 

vote “FOR” the Consolidation Resolution then the Consolidation can be effected, at the Board’s discretion, whether the
Company is organized under the jurisdiction of either British Columbia or in Ontario.

What is the quorum requirement?

A quorum of shareholders is necessary to hold a valid meeting. A quorum will be present if a shareholder holding one or more outstanding share(s) entitled to vote are present at the meeting in person or represented by proxy.

Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote through the internet at the meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the meeting stands adjourned to the same day in the next week at the same time and place.

How can I find out the results of the voting at the Annual Meeting?

Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a press release reported by a national news service in Canada.

What proxy materials are available on the internet?

This Information Circular/Proxy Statement and the Company’s Audited Consolidated Financial Statements for the years ended March 31, 2026 and 2025 and Annual Management Discussion and Analysis for the years ended March 31, 2025 and 2024 are available on the Company’s website at www.ibatterymetals.com/investors.

Who is paying for this Information Circular/Proxy Statement?

The Company anticipates first mailing definitive copies of this Information Circular/Proxy Statement to shareholders of record on or about October [9], 2026 in conjunction with a solicitation of proxies by management of the Company. We are asking for your proxy and will pay all of the costs associated with asking for shareholders’ proxies for the 2026 Annual Meeting. In addition to the use of the mail, proxies may be solicited by the Directors, officers and employees of IBAT by personal interview, telephone or otherwise. Directors, officers and employees will not be additionally compensated, but may be reimbursed for out-of-pocket expenses in connection with solicitation. Arrangements also will be made with brokerage houses and other custodians, nominees and fiduciaries for the forwarding of solicitation material to beneficial owners holding our shares in street name, and we will reimburse custodians, nominees and fiduciaries for reasonable out-of-pocket expenses in connection with the forwarding of solicitation material.

PROPOSAL 1

SETTING THE NUMBER OF DIRECTORS

The authority to determine the number of directors of the Company rests with the Shareholders. The Company's Articles (the “Articles”) stipulate that the Board shall consist of the greater of: (a) three directors, and (b) the number of directors most recently set by ordinary resolution of the shareholders.

On October 27, 2025, the Board held a meeting whereby they considered and passed a motion to recommend to shareholders that the size of the Board for the ensuing year be set at five (5).

At the Annual Meeting, shareholders will be asked to pass an ordinary resolution to set the number of directors of the Company for the ensuing year at five (5).

Vote Required and Board Recommendation

The number of directors will be approved if the affirmative vote by the majority of Common Shares present in person or represented by proxy at the Annual Meeting and entitled to vote are voted in favor of the resolution to set the number of directors at five (5) for the ensuing year. If this proposal is not approved, then the number of directors will continue to be six and their will be a vacancy which can be filled by the Board.

The Board recommends that Shareholders vote “FOR” this resolution to fix the number of directors at five (5). Unless authority to do so is withheld, the persons named in the enclosed form of proxy intend to vote “FOR” the resolution to fix the number of directors at five (5).

PROPOSAL 2

ELECTION OF DIRECTORS

Our Board of Directors currently consists of six directors. The current terms of the directors will expire immediately before the Annual Meeting, or, if sooner, upon the director’s death, resignation or removal.

The Corporate Governance, Nominating and Compensation Committee (the “CGNC Committee”) seeks to assemble a Board that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise and high-level management experience necessary to oversee and direct the Company’s business. To that end, the members of the CGNC Committee, together with the other independent directors of the Board, have identified and evaluated nominees in the broader context of the Board’s overall composition, with the goal of recruiting members who complement and strengthen the skills of other members and who also exhibit integrity, collegiality, sound business judgment and other qualities that the CGNC Committee members and independent directors of the Board view as critical to effective functioning of the Board. Upon Mr. Mills resignation from the Board in July 2026, the CGNC Committee recommended and the Board appointed Mr. Colangelo to serve the remaining port of Mr. Mills' term.

Based on the foregoing criteria, the CGNC Committee decided to reduce the size of the Board from six directors to five directors concurrently with the Annual Meeting and to nominate each of Jacob Warnock, James Schultz, Keith Solar, John Souther, and Scott Colangelo to serve as directors for the one-year term commencing at the Annual Meeting. Dr. Burba was not re-nominated to serve on the Board.

Each director to be elected and qualified will hold office until immediately before the next annual meeting of shareholders or, if sooner, until the director’s death, resignation or removal. Notwithstanding the foregoing, directors are elected by a majority of the votes cast (50% plus 1) by the shareholders present in person or represented by proxy and entitled to vote on the election of directors.

The following table sets forth the proposed management slate of the directors at the Meeting and their respective positions. Dr. John Burba will continue as a director until the Meeting. Please refer to the section of this proxy entitled "Beneficial Ownership" for the number of shares owned by each of the director nominees.

Each of the above listed director nominees has consented to serve as a director if elected, and each director elected will be to serve a one-year term.

Current Board and Nominees

The brief biographies below include information, as of the date of this Information Circular/Proxy Statement, regarding the specific and particular experience, qualifications, attributes or skills of each director nominee that led the members of the CGNC Committee and the other independent directors of the Board to conclude that the person
should serve as a director as of the date of this Information Circular/Proxy Statement.to conclude that the person should serve as a director as of the date of this Information Circular/Proxy Statement.

Jacob Warnock

Mr. Warnock joined the Board in February 2024 as the nominee of EV Metals in connection with the Company’s February 2024 financing transaction. He currently serves as Chief Executive Officer of Silver Creek Resources, LLC, a company specializing in mineral and royalty acquisitions of high-growth oil and gas rights in top-tier U.S. basins. Since 2020, he has overseen operations and acquisitions in the Eagle Ford and Haynesville Shale.

Previously, Mr. Warnock was the Managing Partner of Delago Resources, LLC, a Texas-based upstream oil and gas company focused on acquiring and developing oil and gas reserves. In 2019, he played a pivotal role in the successful $185 million sale of Delago’s assets to Marathon Oil. Over the last five years, he has directed the acquisition of more than $100 million in mineral interests across Texas and Louisiana, particularly in the Haynesville and Eagle Ford shale. A seasoned investor in the energy and infrastructure space, Mr. Warnock is also an active investor in emerging companies and startups, including Fermi America. His anchor investment and strategic involvement propelled the company’s rapid early-stage growth and contributed to its successful dual listing on both the Nasdaq and the London Stock Exchange. A serial entrepreneur, Mr. Warnock currently manages 18 companies and brings more than 20 years of experience founding and leading upstream oil and gas enterprises, as well as structuring and operating multiple joint ventures across several U.S. basins. He holds a Bachelor of Science in Business Management from Midwestern State University.

Mr. Warnock brings to the Board expertise in leasing, curative, permitting, surface operations, facility construction, pipelines, negotiations and strategic exits.

James Schultz

Mr. Schultz joined us as a director in October 2024. Mr. Schultz founded Open Prairie Ventures, Inc. in 1999, a private capital management company, and has served as its Chairman and Chief Executive Officer since 1999. He previously led and oversaw the management of five private equity funds with investments in innovative technologies spanning agriculture, advanced materials, medical devices, and information systems. Mr. Schultz also served in newly elected State of Illinois Governor Bruce Rauner’s cabinet as the Director of the Illinois Department of Commerce and Economic Opportunity. Currently, Mr. Schultz is a member of Prime Banc Corporation/Dieterich Bank Board’s Asset/Liability Management Committee (Chair) along with serving on the Loan Committee. He earned his MBA in Finance and Entrepreneurship from the Kellogg School of Management at Northwestern University, a Juris Doctor Degree from DePaul University College of Law, and a Bachelor of Business Administration from Southern Methodist University.

Mr. Schultz brings to the Board expertise in advanced materials, semiconductor, software development, e-commerce, construction, financial services and information technology.

Keith Solar

Mr. Solar joined us as a director in November 2024. Mr. Solar is a founding partner at Parks & Solar, LLP, a boutique law firm of which he has been managing partner since June 2017. Mr. Solar specializes in water law, with a sub-specialties in desalination and potable reuse. Since 2012, he has represented IDE Americas, Inc., a world leader in water treatment solutions, including the development, engineering, construction, and operation of enhanced desalination and industrial water treatment plants. From 2002 to 2024, Mr. Solar served as special counsel to the City of Carlsbad, which he assisted in negotiating land use and water purchase agreements, respectively, for the Claude “Bud” Lewis Carlsbad Seawater Desalination Plant, the largest desalination plant in the Western Hemisphere. From 2000 to 2006, Mr. Solar served as general counsel to Basin Water, Inc., which focused on treating contaminated water at the well head primarily through ion-exchange technology and became publicly traded on Nasdaq following its initial public offering in May 2006. From 2000 to 2009, Mr. Solar served as a member of the board of directors of Basin Water, Inc., including as chair of its compensation committee from 2006 to 2009 and as chair of its nominating and governance committee from 2007 to 2009. Mr. Solar has authored several published commentaries on water issues and is a lecturer at local and international water conferences and CLE programs. Mr. Solar earned his Juris Doctor, with highest distinction, from McGeorge School of Law, University of the Pacific in 1985, and his A.B. With Great Distinction from Indiana University in 1982. He is admitted to practice law in California, Texas and Tennessee.

Mr. Solar brings to the Board significant legal and governance experience representing public and private clients regarding water rights and water-related issues, with particular emphasis in desalination and potable reuse as well as public company chair and committee experience on public company boards.

John Souther

Mr. Souther joined us as a director in November 2024. He is a technology and operating executive with more than 15 years of leadership experience across industrials, technology, residential services, retail, consumer packaged goods, and consulting. He currently serves as Chief Information Officer of Horizon Group Holding, a private equity-backed, multi-brand residential services platform, where he aligns technology strategy directly to revenue growth, margin expansion, operational scalability, and enterprise value creation. Previously, Mr. Souther led digital strategy for a $10 billion Carrier Corporation business portfolio, including ERP transformation, cloud migration, connected solutions, cybersecurity oversight, AI- and IoT-enabled energy management, and workforce transformation across North America and EMEA. He has served in executive forums and audit committees addressing financial reporting, audit compliance, compensation structures, enterprise risk management, cybersecurity, technology transformation, and capital allocation tied to operating performance. Mr. Souther holds an MBA from Harvard Business School and a BA in Government from Harvard College.

Mr. Souther brings to the Board significant experience driving digital transformation and operational excellence across diverse industries — including industrials, retail, technology, and consumer packaged goods.

Scott Colangelo

Mr. Colangelo joined us as a director in August 2026. He currently is the Chairman, Managing Partner and Co-Founder of Prime Capital Investment Advisors (“PCIA”), a nationally recognized registered investment advisory firm, where he has served since 2017. He also serves as Managing Director of Qualified Plan Advisors, a role he has held since 1999. Prior to co-founding PCIA, Mr. Colangelo served as Vice President and Shareholder of Lawing Financial, where he held various leadership positions for nearly two decades. Mr. Colangelo holds a Bachelor of Science in Finance from Kansas State University. Mr. Colangelo was identified as a director candidate by Jacob Warnock, a member of our Board of Directors.

Mr. Colangelo brings to the Board significant experience in investment management, corporate strategy and executive leadership.

Vote Required and Board Recommendation

The Board has adopted a majority voting policy, pursuant to which each director should be elected by the majority of the votes cast by the shareholders represented in person or by proxy at any meeting for the election of directors. If any nominee for election as director receives, from the Common Shares voted at the meeting in person or by proxy, a greater number of votes “withheld” than votes “for” his or her election, the director will be expected to tender his or her resignation to the chairman of the Board following the meeting, to take effect upon acceptance by the Board. The CGNCC will expeditiously consider the director's offer to resign and make a recommendation to the Board whether to accept such an offer. Within 90 days of the meeting of the Company’s shareholders, the Board will make a final decision concerning the acceptance of the director's resignation. The process applies only in circumstances involving an “uncontested” election of directors – where the number of director nominees does not exceed the number of directors to be elected and where no proxy materials are circulated in support of one or more nominees who are not part of the slate supported by the Board for election at the meeting. Subject to any corporate law restrictions, where the Board accepts the offer of resignation of a director and that director resigns, the Board may exercise its discretion with respect to the resulting vacancy and may, without limitation, leave the resultant vacancy unfilled until the next annual meeting of the shareholders, fill the vacancy through the appointment of a new director whom the Board considers to merit the confidence of the Company’s shareholders, or call a special meeting of the shareholders to elect a new nominee to fill the vacant position.

The vote required to elect our five directors for a term expiring immediately before the 2027 annual meeting of shareholders or, if sooner, until the director’s death, resignation or removal, is by a majority of the votes cast (50% plus 1) by the shareholders present in person or represented by proxy and entitled to vote on the election of directors.

The Board recommends that you vote “FOR” each of the five director nominees.

CORPORATE GOVERNANCE

Board Size and Term

Our Articles provide that our Board of Directors shall consist of at least three directors and that each director shall hold office until the close of the next annual general meeting of our shareholders, or until his or her successor is duly elected or appointed, unless his or her office is earlier vacated. Our Board of Directors previously consisted of seven directors, however, as a result of Mr. Mills resignation in July 2026 the Board of Directors approved reducing the size of the the Board from seven directors to six directors. In Connection with Dr. John Burba's decision to not stand for re-election at the Meeting, the Board intends to reduce the size of the Board to five directors.

Family Relationships

There are no family relationships among any of our directors or executive officers.

Director Independence

As we are listed on the TSXV, we evaluate whether our directors are “independent” in accordance with National Policy 58-201 - Corporate Governance Guidelines (“NP 58-201”) issued by the British Columbia Securities Commission (“BCSC”). NP 58-201 states that “a director is independent if he or she would be independent for the purposes of National Instrument 58-101 Disclosure of Corporate Governance Practices (“NI 58-101”) NI 58-101(2) states that “[i]n British Columbia, a director is independent if . . . a reasonable person with knowledge of all the relevant circumstances would conclude that the director is independent of management of the issuer and of any significant security holder ” In addition, we evaluate whether our directors who serve on our Audit Committee meet the enhanced level of independence required for Audit Committee members in accordance with National Instrument 52-110 “Audit Committees” (“NI 52-110”). NI 52-110 provides under Section 1.4 “Meaning of Independence” that “(1) [a]n audit committee member is independent if he or she has no direct or indirect material relationship with the issuer.”

In determining whether a “material relationship” exists NI 52-110 provides certain situations where an individual is deemed to have a material relationship, which include but are not limited to:

Consistent with TSXV rules, our Board conducted its annual review of director independence. During the review, our Board considered relationships and transactions since incorporation between each director or any member of her immediate family, on the one hand, and us on the other hand. The purpose of this review was to determine whether any such relationships or transactions were inconsistent with a determination that the director is independent. Our Board of Directors has determined that each of our directors (i.e., James Schultz, Keith Solar, John Souther, and Scott Colangelo), other than Dr. John Burba and Mr. Jacob Warnock, are considered to be “independent” in accordance with NI 58-101. None of the directors hold directorships in other reporting issuers.

Directors, Director Term Limits and Gender Diversity

In late 2014, the securities regulators of Canada (other than Alberta and British Columbia) adopted an amendment to NI 58-101 requiring companies to include disclosure in their management Information Circular/Proxy Statementor annual information forms, as applicable, in respect of director term limits and requiring new disclosure regarding the representation of women on boards and in executive office positions. As of fiscal year end, March 31, 2026, Norma Garcia, the Company’s General Counsel, Corporate Secretary is a women. The Company currently does not have written policies in respect of the selection of individuals as nominees for election as directors, director term limits and gender diversity.

The CGNCC is responsible for identifying and recommending to the Board potential candidates to become directors of the Company. While there are no specific written criteria for Board membership, the Company does seek to attract and retain directors with an understanding of the Company's business and a particular knowledge which would assist in guiding management of the Company. The CGNCC also considers the composition of the Board at the time of such review with a view to ensuring that the backgrounds, experiences, and knowledge-base of the members of the Board are diverse and complementary. The Board, taking into consideration the CGNCC's recommendations, is responsible for selecting the nominees for election to the Board, for recommending individuals for appointment as directors to fill vacancies, and determining whether a nominees or appointee is independent.

The Company does not impose term limits on its directors, believing that this arbitrary mechanism for removing directors can result in valuable, experienced directors being forced to leave the Board. The Company believes that the best means to achieving Board renewal is for it to happen organically, and in tandem with the nomination process managed by the CGNCC that takes into consideration a number of factors including identifying and selecting individuals who possess the skills, competencies, knowledge and have the business acumen, time available and independence to effectively discharge their responsibilities and best serve the Company.

The Company does not support the adoption of quotas or targets regarding gender representation on the Board or NEO positions. All Board appointments are made on merit, in the context of the skills, experience, independence, knowledge and other qualities which the Board as a whole requires to be effective, with due regarding for the benefits of diversity, including the level of representation of women to the Board.

With respect to the appointment of NEOs, the Company recruits and promotes on the basis of an individual's competence, qualification, experience, and performance, regardless of gender, age, or other aspects of diversity.

Election of Directors: the Board has adopted a majority voting policy, pursuant to which each director should be elected by vote of a majority (50% plus 1) of the votes cast by shareholders in person or represented by proxy at any meeting for the election of directors. If any nominee for election as director receives, from the Common Shares voted at the meeting in person or by proxy, a greater number of votes “withheld” than votes “for” his or her election, the director will be expected to tender his or her resignation to the Chairman of the Board following the meeting, to take effect upon acceptance by the Board. The CGNCC will expeditiously consider the director's offer to resign and make a recommendation to the Board whether to accept such an offer. Within 90 days of the meeting of the Shareholders, the Board will make a final decision concerning the acceptance of the director's resignation. The process applies only in circumstances involving an “uncontested” election of directors – where the number of director nominees does not exceed the number of directors to be elected and where no proxy materials are circulated in support of one or more nominees who are not part of the slate supported by the Board for election at the Meeting. Subject to any corporate law restrictions, where the Board accepts the offer of resignation of a director and that director resigns, the Board may exercise its discretion with respect to the resulting vacancy and may, without limitation, leave the resultant vacancy unfilled until the next annual meeting of the Shareholders, fill the vacancy through the appointment of a new director whom the Board considers to merit the confidence of the Shareholders, or call a special meeting of the Shareholders to elect a new nominee to fill the vacant position.

Board Committees

As of the date of this Information Circular/Proxy Statement the following persons serve as members of the Board of Directors and on the following Committees:

Audit Committee

During the fiscal year ended March 31, 2026, the Audit Committee of the Board consisted of three members, John Souther, James Schultz and Keith Solar, with Mr. Schultz being the Chairman of the Audit Committee. Commencing in August 2026, Mr. Solar stepped down from the Audit Committee and Mr. Colangelo was appointed to the Audit Committee. The Audit Committee met eighteen times during the fiscal year ended March 31, 2026.

Our Board of Directors has determined that each of the Audit Committee members meets the heightened Audit Committee independence requirements under NI 52-110 and Rule 10A-3 of the Exchange Act, and that James Schultz is considered an “audit committee financial expert,” as defined in applicable SEC regulations.

The Audit Committee is responsible for overseeing our financial reporting process on behalf of the Board, including overseeing the work of the independent auditors who report directly to the Audit Committee. The specific responsibilities of our Audit Committee, among others, include:

Our Board of Directors has adopted a written charter for our Audit Committee, which is appended to this Circular as Schedule "A" and is available on our website at www.ibatterymetals.com.

Compensation Committee

During the fiscal year ended March 31, 2026, the Compensation Committee consists of Keith Solar, John Souther and Jacob Warnock, with Mr. Solar serving as Chairman of the Compensation Committee. As of the date of this Information Circular/Proxy Statement, the same three directors sit on the Compensation Committee. The Compensation Committee met nine times during the fiscal year ended March 31, 2026.

The Compensation Committee as appointed by the Board is designed to enable the Board to discharge its responsibilities and obligations with respect to:

Our Board of Directors has adopted a written charter for our Compensation Committee, which is available on our website at www.ibatterymetals.com.

Compensation Committee Interlocks and Insider Participation

During the fiscal year ended March 31, 2026, the Compensation Committee consists of Keith Solar, John Souther and Jacob Warnock. During the fiscal year ended March 31, 2026, none of these directors was an officer (as defined in Rule 3b-2 under the Exchange Act) or employee of the Company, or formerly an officer of the Company. During the fiscal year ended March 31, 2026, none of our executive officers served on the compensation committee or board of any company that employed any person that served as a member of the Compensation Committee or our Board.

Corporate Governance and Nominating Committee

During the fiscal year ended March 31, 20-26 the Corporate Governance and Nominating Committee (the “CGNC Committee”) consisted of Keith Solar, John Souther and Jacob Warnock, with Mr. Solar serving as Chairman of the CGNC Committee. As of the date of this Information Circular/Proxy Statement, the same three directors sit on the
Compensation Committee.

The CGNC Committee as appointed by the Board is designed to enable the Board to discharge its responsibilities and obligations with respect to:

Our Board of Directors has adopted a written charter for our CGNC Committee, which is available on our website at www.ibatterymetals.com.

Board Meetings and Practices

During the fiscal year ended March 31, 2026, the Board held a total of fifteen meetings. Each incumbent director attended at least 75% or more of the aggregate of the total number of meetings of the Board and the total number of meetings held by all committees of the Board on which he served. During the fiscal year ended March 31, 2026, the Audit Committee met eighteen times, the Compensation Committee met nine times and the CGNC Committee met two times.

We encourage all directors to attend the annual meetings of our shareholders, but attendance is not required.Our 2025 Annual Meeting was attended by six directors.

Board Oversight of Enterprise Risk

The Board is actively involved in the oversight and management of risks that could affect the Company. This oversight and management is conducted primarily through the committees of the Board identified above but the full Board has retained responsibility for general oversight of risks. The Audit Committee is primarily responsible for overseeing the risk management function, specifically with respect to management’s assessment of risk exposures (including risks related to liquidity, credit, operations, regulatory compliance, and cybersecurity, among others), and the processes in place to monitor and control such exposures. The other committees of the Board consider the risks within their areas of responsibility. The Board satisfies its oversight responsibility through full reports by each committee chair regarding the committee’s considerations and actions, as well as through regular reports directly from officers responsible for oversight of particular risks within the Company.

Related Party Transactions

The Board has adopted a written related party transactions policy, which is administered by the Audit Committee. This policy applies to any transaction or series of related transactions involving a related party and the Company or any subsidiary. However, under U.S. securities laws, the Company may not make any loan or other extension of credit to any of its directors or executive officers.

For purposes of the policy, “related party” consist of executive officers, directors, director nominees, any shareholder beneficially owning more than five percent of any class of our voting securities, and immediate family members of any such persons. In reviewing related party transactions or potential conflict of interest, the Audit Committee will be provided with written materials when appropriate and will consider all relevant facts and circumstances, including without limitation the commercial reasonableness of the terms, the benefit and perceived benefit, or lack thereof, to the Company, opportunity costs of alternate transactions, the materiality and character of the Related Party’s direct or indirect interest, and the actual or apparent conflict of interest of the Related Party. If the Audit Committee determines that the potential conflict of interest issues and other circumstances warrant, the Audit Committee shall consider recommending to the Board that the proposed transaction be approved by the independent directors.

No member of the Audit Committee may participate in any discussion, consideration, approval or ratification of a proposed related party transaction for which he or she or any of his or her immediate family members is the related party. All related party transactions will be disclosed in filings as required under applicable securities laws.

Please refer to the section below entitled “Certain Relationships And Related Party Transactions” for a discussion of the related party transactions that occurred during the fiscal year ended March 31, 2026.

Advance Notice Provisions

Our Articles contain provisions known as “Advance Notice Provisions”, which provide that advance notice to the Company must be made and the procedures set out in the Articles must be followed for persons to be eligible for election to the Board of Directors. Nomination of persons for election to the Board of Directors may only be made at an annual meeting of shareholders or at a special meeting of shareholders called for any purpose, which includes the election of directors.

Among other things, the Advance Notice Provisions fix a deadline by which holders of record of Common Shares must submit director nominations to us prior to any annual or special meetings of shareholders and set forth

The specific information that a shareholder must include in the written notice to the Company for an effective nomination to occur. No person will be eligible for election as a director of the Company unless nominated in accordance with the provisions of the Advance Notice Provisions.

In the case of an annual meeting of shareholders, notice to us must be made not less than 30 or more than 65 days prior to the date of the annual meeting; provided, however, that if the annual meeting is to be held on a date that is less than 50 days after the date on which the first public announcement of the date of the annual meeting was made, notice may be made not later than the close of business on the 10th day following such public announcement. In the case of a special meeting of shareholders (which is not also an annual meeting), notice to us must be made not later than the close of business on the 15th day following the day on which the first public announcement of the date of the special meeting was made. Management is seeking to amend these timelines at the Meeting to comply with applicable U.S. securities requirements.

The Board of Directors may, in its sole discretion, waive any requirement of the Advance Notice Provisions.

Communications With the Board of Directors

The Company’s Board has adopted a formal process by which shareholders and other interested parties may communicate with the Board or any of its directors. Shareholders and other interested parties who wish to communicate with the Board may do so by sending written communications addressed to the Secretary of International Battery Metals Ltd. at 6100 Tennyson Parkway, Suite 240, Plano, Texas 75024. Each communication must set forth the name and address of the interested party or the Company shareholder on whose behalf the communication is sent and the number of Company shares that are owned beneficially by such shareholder as of the date of the communication. Each communication will be reviewed by the Company’s Secretary to determine whether it is appropriate for presentation to the Board or relevant directors. Communications determined by the Company’s Secretary to be appropriate for presentation to the Board or any relevant directors are submitted to the Board or relevant directors on a periodic basis.

Code of Conduct and Code of Ethics

We have adopted a written Code of Business Conduct and Ethics (the "Code") that applies to all of our directors, officers, and employees, including our Chief Executive Officer, Chief Financial Officer and Controller. The Code addresses, among other things, conflicts of interest, related party transactions, compliance with laws and regulations, protection and proper use of corporate opportunities, protection and proper use of corporate assets, confidentiality of corporate information, fair dealing with customers, suppliers, competitors and employees, insider trading, whistle blowing, honest and ethical conducts, and integrity of business records and financial disclosure. The Code includes provisions applicable to our senior financial officers designated to promote honest and ethical conduct, accurate and timely disclosure in our periodic reports, and compliance with applicable laws, rules, and regulations. . Any waivers of the Code for our executive officers or directors must be approved by the Board of Directors and will be promptly disclosed. The Code is available on our website at www.ibatterymetals.com, under the Investor Relations—Governance section. We intend to disclosure any amendments to or waivers of the Code on our website within four business days following the date of the amendment or waiver.

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10% of a registered class of our equity securities, to file with the SEC reports of ownership and changes in ownership of our Common Shares. Executive officers, directors and greater than 10% shareholders are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file.

Based on the review of copies of such reports furnished to us and written representations that no other reports were required, we believe that, during fiscal 2026, our executive officers, directors and greater than 10% beneficial owners timely complied with all Section 16(a) filing requirements applicable to them, except that EV Metals VI LLC, EV Metals 7 LLC and

EV Metals 9 LLC, entities controlled by our director, Jacob Warnock, filed their Form 3 late due to an administrative error.

Orientation and Continuing Education

While the Company currently has no formal program to orient new directors to the role of the Board, its committees and the nature and operation of the Company's business, it has been the Company's practice for new directors to be thoroughly briefed by management of the Company and to be provided the opportunity to discuss with management, both formally and informally, the Company's activities. New directors are provided with copies of relevant policies and similar materials to ensure that they are familiarized with the Company and its business as well as the procedures of the Board.

The Corporate Governance and Nominating Committee has responsibility for overseeing development of any orientation programs for new directors. Although the Company does not have a formal program for the continuing education of directors, the Board ensures that its directors maintain the skills and knowledge necessary to meet their obligations as directors of the Company by scheduling presentations to the Board from time to time to educate directors and keep them informed of developments within the Company and of disclosure and governance requirements and standards.

EXECUTIVE OFFICERS

The following table sets forth our executive officers as of the date of this Information Circular/Proxy Statement and their respective positions.

James Garrett Galloway, Interim Chief Executive Officer and Senior Vice President of Business Development

Mr. Galloway serves as our Senior Vice President of Business Development since May 2025. He has over 15 years of experience in the energy industry including multiple finance positions, mergers and acquisitions, complex transactions, and debt and equity capital markets. Prior to IBAT, Mr. Galloway was Vice President of Finance at QuarterNorth Energy, where he worked in various roles from August 2021 until May 2024 and played a key role in establishing the Company's strategy and its successful divestiture to Talos Energy (NYSE: TALO), which ultimately returned approximately $1.9 billion in capital to shareholders. Prior to that, he served in various finance and corporate roles at Fieldwood Energy LLC from August 2013 until August 2021. Prior experience includes increasing finance and corporate roles at Midstates Petroleum and Dynamic Offshore Resources. He began his career in the energy group of BOK Financial focused on reserved based lending and corporate banking needs of upstream oil and gas clients. Mr. Galloway has a bachelor's degree in business and finance from the University of Alabama.

Michael Rutledge, Chief Financial Officer

Mr. Rutledge joined us as our Interim Chief Financial Officer in March 2025 and then as our Chief Financial Officer in June 2025. From September 2021 to October 2024, Mr. Rutledge served as Chief Financial Officer, President of ADDvantage Technologies Group. From 2015 to 2020, Mr. Rutledge served as Vice President, Finance at SomnoMed Group prior to spending two years as the Chief Financial Officer at BG Staffing, where he played a key role in taking the company public and raising $16 million. Prior to that. he spent three years as Vice President of Finance with Cantel Medical Corporation, a publicly owned manufacturer of medical products, which acquired Byrne Medical, Inc., where he was the Chief Financial Officer. He joined Byrne Medical from N.F. Smith & Associates, a privately owned distributor of electronic components, where he spent four years as the Chief Financial Officer. Mr. Rutledge began his career at Ernst & Young, where he spent 12 years ultimately as Senior Audit Manager and was involved in several IPOs. Mr. Rutledge is a CPA in the State of Texas and holds a Bachelor of Business Administration in Accounting from Texas A&M University.

Dr. John Burba, Chief Technology Officer

Dr. Burba joined us in 2018 in connection with our acquisition of NAL and SAL which he founded in 2016. Dr. Burba served as our Chief Executive Officer from 2018 until December 2022, our Chief Technology Officer from 2018 through present and a member of our Board since 2018. In November 2024, Dr. Burba was appointed as Chairman of the Board. Dr. Burba is a physical chemist and has deep experience in lithium and other mineral extraction technologies and created the patents upon which our current technology is based. He has more than 40-years of experience working on a number of lithium brine projects in North and South America, notably with Dow Chemical Co., FMC Corp., and Chemtura Corp. Dr. Burba served as CEO of Simbol Materials, a company focused on the recovery of lithium from geothermal brines in Southern California from 2013 to 2016. Under his leadership, Simbol Materials successfully developed a proprietary process capable of producing low cost, high-purity lithium products from brines that were previously believed to be too high in contaminants to be economically processed. Prior to that, Dr. Burba served as Chief Technology Officer and Executive Vice President of Molycorp Inc. since December 2009, where he was instrumental in identifying and developing numerous rare earths technologies as part for the Project Phoenix re-development of the Mountain Pass facilities. Dr. Burba received a Bachelor of Science in Chemistry and completed doctoral studies in Physical Chemistry at Baylor University.

Norma Garcia, General Counsel and Corporate Secretary

Ms. Garcia serves as our General Counsel and Corporate Secretary since November 2024. She has over 20 years of extensive legal and executive leadership experience with publicly traded companies, having held senior roles overseeing corporate governance, human resources, risk management, and contract management. Her background includes serving as General Counsel, Corporate Secretary and Chief Human Resource Officer with Stryve Foods (NASDAQ: SNAX), Vice

President and Assistant General Counsel with oversight of legal, compliance, employment, and risk management matters with Rent-A-Center (NASDAQ: UPBD), and Assistant General Counsel at WalMart (NYSE: WMT), where she managed compliance, litigation, real estate, and labor and employment issues. She began her legal career as an Assistant District Attorney in Texas, where she served as Chief of Domestic Violence and prosecuted numerous jury trials. Ms. Garcia received her Juris Doctor degree from Oklahoma City University School of Law.

EXECUTIVE COMPENSATION

As an emerging growth company under the JOBS Act, we have opted to comply with the executive compensation disclosure rules applicable to “smaller reporting companies” as such term is defined in the rules promulgated under the Securities Act, which permit us to limit reporting of executive compensation to our principal executive officer and our two other most highly compensated executive officers.

The following table contains compensation data for our named executive officers for the fiscal years ended March 31, 2026 and 2025. In this section, “Named Executive Officer” or “NEO” means (i) all individuals serving as the our principal executive officer or acting in a similar capacity during the last completed fiscal year (ii) each of the two most highly compensated executive officers, other than the principal executive officer, who were serving as executive officer of us at March 31, 2026 and 2025 and whose total salary and bonus exceeds $100,000, and (iii) up to two additional individuals for whom disclosure would have been provided under clause (ii) except that the individual was not serving as an executive officer of us at March 31, 2026 and 2025. For the 2026 and 2025 fiscal year, our NEOs are as follows:

Iris Jancik served as Chief Executive Officer until April 7, 2025.

Summary Compensation Table

The following table sets forth all compensation paid to or earned by the NEOs for the last two fiscal years ended March 31, 2026 and March 31, 2025.

Compensation Discussion and Analysis

Our Compensation Philosophy

The Company's executive compensation program (the “Compensation Program”) is comprised of both base salary, and long-term incentives. Together, these components support the Company's long-term growth strategy and the following objectives:

The Compensation Program is designed to reward high performance, to retain and motivate key employees, consultants, directors, and NEOs, and to promote an environment where such individuals are motivated to act in the best interests of the Company. These individuals are awarded for efforts directly related to the advancement of the Company's business and technology, as well as, delivering strong shareholder return performance.

The Compensation Committee meets regularly to assess the current compensation paid to key-employees, directors, NEOs, and consultants of the Company, and provides recommendations based on the realized growth of the Company. As the Company's business strategy is unique with respect to the Company's advancement of its modular direct lithium extraction technology, its ability to benchmark its compensation paid to such key- employees, directors, NEOs and consultants is limited.

Elements of Compensation

The compensation of the Company’s executive officers includes two major components: (i) a base fixed amount of salary, and (ii) long-term equity incentives granted from time to time under the 2025 Omnibus Equity Incentive Plan.

The compensation paid to the NEOs for the year ended March 31, 2026, is summarized above in the “Summary Compensation Table.”

Base Salary

Base salary is compensation for discharging job responsibilities and reflects the level of skills and capabilities demonstrated by the executive. Annual salary adjustments take into account the market value of the role and the executive's demonstration of performance against defined metrics year over year.

Long-Term Incentives

On December 17, 2025, Shareholders approved the adoption of the 2025 Omnibus Incentive Plan (the “Plan”) which replaced the Company’s prior Stock Option Plan and Restricted Share Unit Plan. Pursuant to the Plan, the Company is able to issue share-based long-term incentives. All directors, officers, employees and consultants of the Company and/or its subsidiaries (collectively, the “Service Providers”) are eligible to receive awards under the Plan, other than any person who is, or is an associate or affiliate of, a beneficial owner of more than 10% of the Common Shares. The purpose of the Plan is to (i) develop the interest of Service Providers in the growth and development of the Company by providing such persons with the opportunity to acquire a proprietary interest in the Company; (ii) attract and retain valuable Service Providers to the Company with a competitive compensation mechanism; and (iii) align the interests of the participants with those of Shareholders by devising a compensation mechanism which encourages the prudent maximization of value creation for Shareholders and long-term growth.

The types of awards available under the Plan include options (“Options”), restricted share awards (“RSAs”), restricted share units (“RSUs”), performance share units (“PSUs”), deferred share units (“DSUs”), stock appreciation rights (“SARs”) and dividend-equivalent rights (collectively, “Awards”). The Plan has replaced the Company’s Rolling 10% Incentive Share Option Plan (the “Prior Option Plan”), under which there were 1,300,000 Common Shares reserved for issuance pursuant to Options outstanding as of the date of this Information Circular/Proxy Statement (the “Prior Options”), and the Company’s Amended and Restated Restricted Share Unit Plan (the “Prior RSU Plan”), under which there were 2,516,667 Common Shares reserved for issuance pursuant to unvested RSUs outstanding as of the date of this Information Circular/Proxy Statement (the “Prior RSUs”). The maximum number of Common Shares available and reserved for issuance, at any time, under the Plan, together with any other security-based compensation arrangements adopted by the Company, including the Prior Option Plan and the Prior RSU Plan, shall not exceed 20% of shares outstanding on December 17, 2025, and therefore the number of Common Shares available under the Plan is 43,058,439 Common Shares.

The following is a summary of the key terms of the Plan:

Agreements with NEOs

Agreements with Messrs. Rutledge and Galloway

During the fiscal year ended March 31, 2026 we were parties to employment agreements with Mr. Michael Rutledge to serve as our Chief Financial Officer (the “Rutledge Employment Agreement”) and Mr. James Garrett Galloway to serve as SVP Corporate Development (the "Galloway Employment Agreement"). Each of the Rutledge Employment Agreement and the Galloway Employment Agreement has an initial two-year term and each automatically renews each year thereafter for a period of one year (“Renewal Date”), provided, neither party has provided written notice within 60 days of the Expiration Date or the Renewal Date, as the case may be, of such party’s intention to terminate such employment agreement. Each executive is eligible to participate in all benefit plans and programs made available by us for our employees, including participation in bonus and incentive compensation plans and programs established for officers and directors of the Company on terms determined by the Board.

Each of the Employment Agreements, as amended, entitles the executive to: (i) an annual base salary subject to annual review by the CGNC Committee ($350,000 in the case of Mr. Rutledge and $300,000 in the case of Mr. Galloway) and (ii) the ability to participate in the Company’s annual bonus program based on the Company’s financial performance and the Board’s assessment of the executive’s individual performance with a target bonus equal to a specified percentage of his annual base salary (60% in the case of Mr. Rutledge and 50% in the case of Mr. Galloway).

Equity Awards. On November 4, 2025, we entered into an amendment to each of the Rutledge Employment Agreement and the Galloway Employment Agreement pursuant to which the parties clarified the terms of various equity awards that had been required to be issued pursuant to the initial agreement (which had not yet been issued). As amended, the Employment Agreements provide for specific equity awards as set forth below:

In addition, each of Mr. Rutledge and Mr. Galloway will be entitled to anti-dilution protection with respect to each of the equity awards that are based upon a percentage of Fully Diluted Common Shares.

Upon a Change of Control,a cash payment equal to (i) a specified percentage (0.45% in the case of Mr. Rutledge and 0.40% in the case of Mr. Galloway) of the Company’s then issued and outstanding shares multiplied by the fair market value of all consideration paid (cash or securities) to shareholders in connection with the Change in Control divided by the number of the Company’s then issued and outstanding shares immediately prior to the Change in Control and (ii) to the extent that Production Award has not been issued, an additional cash bonus equal to a specific percentage (0.25% in the case of Mr. Rutledge and 0.20% in the case of Mr. Galloway) of the Company’s fully diluted outstanding Common Shares immediately prior to the Change in Control multiplied by the fair market value of all consideration paid (cash or securities) to shareholders in connection with the Change in Control.

Termination and Change of Control Benefits. Under both the Rutledge Employment Agreement and the Galloway Employment Agreement, in the event that either executive’s employment is terminated by the Company for cause or if the executive terminates his employment without good reason, the executive is entitled to receive: (i) accrued but unpaid base salary, bonus, expense reimbursement and other accrued benefits; (ii) reimbursement for unreimbursed business expenses properly incurred; and (iv) such employee benefits (including equity compensation) to which the executive may have been entitled under an applicable award agreement or benefit plan as of the termination date ((i) through (iv) collectively referred to as “Accrued Amounts”).

Under both the Rutledge Employment Agreement and the Galloway Employment Agreement, in the event that employment is terminated by such executive for good reason or by the Company without cause, the executive is entitled to: (i) the Accrued Amounts; (ii) his then base salary for a specific number of months (10 months in the case of Mr. Rutledge and 10 months in the case of Mr. Galloway), to be paid in periodic installments; (iii) any unpaid bonus with respect to any calendar year preceding the year in which the termination occurs, plus a pro rata portion of his annual bonus as determined by the Board; (iv) reimbursement of premiums for health insurance continuation benefits for a specific number of months (10 months in the case of Mr. Rutledge and 10 months in the case of Mr. Galloway) following his termination; (v) acceleration of vesting of all time based RSUs; and (vi) subject to the actual achievement of the performance-based vesting conditions, continued vesting of any performance-based RSUs that would have vested during the 12 month period following the termination date had such employment continued ((i) through (vi) collectively referred to as the “Separation Benefits”).

In the event the Company terminates either Mr. Rutledge’s or Mr. Galloway's employment without cause or such executive terminates his employment for good reason two and one-half months prior to a Change of Control or within 12 months following a change in control, the executive would be entitled to the Separation Benefits, except that the base salary

would be paid in a single lump sum within 30 days of such termination. The Employment Agreements define “Change of Control” to mean: (i) any “person” as such term is used in Sections 13(d) and 14(d) of the Exchange Act becomes the “beneficial owner”, directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then outstanding voting securities; (ii) consummation of a merger or consolidation of the Company with any other entity or the issuance of voting securities in connection with a merger or consolidation of the Company (or any direct or indirect subsidiary thereof) pursuant to applicable exchange requirements, other than (A) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving or parent entity) at least 50% of the combined voting power of the voting securities of the Company or such surviving or parent entity outstanding immediately after such merger or consolidation or (B) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no “person” (as defined above) is or becomes the beneficial owner, directly or indirectly, of securities of the Company representing 50% or more of either of the then outstanding shares of Common Share or the combined voting power of the Company’s then outstanding voting securities; or (iii) the consummation of the sale, lease or disposition by the Company of all or substantially all of the Company’s assets (or any transaction or series of transactions within a period of twelve (12) months ending on the date of the last sale or disposition having a similar effect).

Each of the Rutledge Employment Agreement and the Galloway Employment Agreement provide that the executive is subject to a one-year non-compete covenant following termination of his employment anywhere in the United States or any other country which the Company operates, regardless of whether the termination is voluntary or involuntary. Each executive is also subject to a one-year non-solicitation covenant following termination of his employment, regardless of whether the termination is voluntary or involuntary.

Interim CEO Letter Agreement. In connection with his appointment as Interim CEO, the Company entered in a letter agreement with Mr. Galloway, effective as of July 26, 2026, which provided Mr. Galloway a monthly bonus of $8,333.33 for each month that he served as Interim CEO. All other provisions of his employment agreement remained the same.

Dr. John Burba, Chief Technology Officer

On June 26, 2018, we entered into an executive employment agreement with Dr. John Burba. Pursuant to the employment agreement, Dr. Burba was hired as our Chief Executive Officer, with a term commencing on June 26, 2018, for an indefinite term unless terminated on account of his death, resignation or disability or terminated by us for cause or without cause (the “Dr. Burba Employment Agreement). Dr. Burba served as our Chief Executive Officer from June 26, 2018, and then assumed the role of Chief Technology Officer on July 26, 2023. In accordance with the Dr. Burba Employment Agreement, he is entitled to an annual base salary of $200,000 (subject to annual review by the CGNC Committee) and is eligible to participate in all benefit plans and programs made available by us for our employees, including participation in bonus and incentive compensation plans and programs established for officers and directors of the Company on terms determined by the Board.

Termination and Change of Control Benefits. Pursuant to the Dr. Burba Employment Agreement, in the event that Dr. Burba’s employment is terminated as a result of death, disability or for cause, he would be entitled to accrued salary, benefits and vacation, including the then unused accrued vacation (the “Dr. Burba Accrued Benefits”), up to and including the date of termination in a single lump sum within 30 days of such termination.

Pursuant to the Dr. Burba Employment Agreement, if the Company terminates Dr. Burba’s employment without cause or if Dr. Burba terminates his employment for good reason, and such termination does not occur within the 24-month period following a change of control, Dr. Burba will be entitled to: (i) the Dr. Burba Accrued Benefits in a single lump sum and (i) an amount equal to Dr. Burba’s target bonus amount.

Pursuant to the Dr. Burba Employment Agreement, if, during the 24-month period following a change of control, the Company terminates Dr. Burba’s employment without cause or Dr. Burba terminates his employment for good reason, Dr. Burba will be entitled to: (i) the Dr. Burba Accrued Benefits in a single lump sum within 30 days of such termination, (ii) a lump sum payment in an amount equal to his base salary at the time of such termination, payable in a lump sum, as well as continuation of his base salary for a period of one year following such termination, and (iii) a lump sum payment in an amount equal to two times his target bonus amount, payable in lump sum.

Dr. Burba is subject to a one-year non-compete covenant following termination of his employment anywhere in North America, Central America, South America, Asia and Australia, regardless of whether the termination is voluntary or involuntary. He is also subject to a one-year non-solicitation covenant following termination of his employment, regardless of whether the termination is voluntary or involuntary.

Joseph Mills, Former CEO

During the fiscal year ended March 31, 2026, we were party to an employment agreement with Mr. Joseph Mills to serve as our Chief Executive Officer (the “Mills Employment Agreement”). The Mills Employment Agreement had an initial three-year term and automatically renewed each year thereafter for a period of one year(“Renewal Date”), provided, neither party had provided written notice within 60 days of the Expiration Date or the Renewal Date, as the case may be, of such party’s intention to terminate such employment agreement. Mr. Mills was eligible to participate in all benefit plans and programs made available by us for our employees, including participation in bonus and incentive compensation plans and programs established for officers and directors of the Company on terms determined by the Board.

On November 4, 2025, we entered into amendment to the Mills Employment Agreement pursuant to which the parties clarified the terms of various equity awards that had been required to be issued pursuant to the initial agreement (which had not yet been issued). In addition, Mr. Mills agreed to forego a portion of his salary until July 31, 2026 in exchange for additional equity.Mr. Mills was entitle the executive to: (i) an annual base salary subject to annual review by the CGNC Committee of $500,000, which increased to $600,000 starting August 1, 2026 and (ii) the ability to participate in the Company’s annual bonus program based on the Company’s financial performance and the Board’s assessment of the executive’s individual performance with a target bonus equal to 100% of his annual base salary. In addition, the Employment Agreement, as amended provided for specific equity awards to Mr. Mills, the unvested portions of which were forfeited in connection with his July 19 2026 resignation.

Termination and Change of Control Benefits.Under the Mills Employment Agreement, in the event that Mr. Mills had been terminated by the Company for cause or if the executive terminated his employment without good reason, the executive would have been entitled to receive: (i) accrued but unpaid base salary, bonus, expense reimbursement and other accrued benefits; (ii) reimbursement for unreimbursed business expenses properly incurred; and (iv) such employee benefits (including equity compensation) to which the executive may have been entitled under an applicable award agreement or benefit plan as of the termination date ((i) through (iv) collectively referred to as “Accrued Amounts”). In addition, in the event that Mr. Mills’ employment had been terminated by such executive for good reason or by the Company without cause, Mr. Mills would have been entitled to: (i) the Accrued Amounts; (ii) his then base salary for 12 months, to be paid in periodic installments; (iii) any unpaid bonus with respect to any calendar year preceding the year in which the termination occurs, plus a pro rata portion of his annual bonus as determined by the Board; (iv) reimbursement of premiums for health insurance continuation benefits for 12 months following his termination; (v) acceleration of vesting of all time based RSUs; and (vi) subject to the actual achievement of the performance-based vesting conditions, continued vesting of any performance-based RSUs that would have vested during the 12 month period following the termination date had such employment continued((i) through (vi) collectively referred to as the “Separation Benefits”).

In the event the Company terminates either Mr. Mills’ employment without cause or such executive terminates his employment for good reason two and one-half months prior to a Change of Control or within12 months following a change in control, the executive would be entitled to the Separation Benefits, except that the base salary would be paid in a single lump sum within 30 days of such termination. The Mills Employment Agreement used the same definition of “Change of Control” as was used in the Rutledge Employment Agreement.

As Mr. Mills resigned he did not receive any severance or other payments from the Company and forfeited all unvested equity following his 60 days notice period.

Iris Jancik, Former CEO

On April 11, 2025, we entered into a Severance and General Release Agreement (the “Jancik Severance Agreement”) with Ms. Jancik. Pursuant to the Jancik Severance Agreement, Ms. Jancik and the Company agreed that her employment would be terminated effective April 11, 2025 and that in connection with such termination she would be entitled to receive, in lieu of the amounts and benefits set forth in the Jancik Employment Agreement, (i) $800,000 to be paid in three periodic installments over a four-month period and (ii) continued health and medical benefits for a period of six months following the date of termination. In exchange, Ms. Jancik agreed to (i) forfeit all vested and unvested stock options and vested and unvested RSUs, (ii) provide a customary general release and waiver of any and all claims relating to her employment with Company, (iii) a twelve-month non-compete for anywhere in the United States and in all other countries where the Company operates through license of its intellectual property or otherwise and (iv) a twelve-month non-solicitation of any of the Company’s employees or independent contractors and any current, former or prospective customers of the Company with whom Ms. Jancik had contact with during her employment.

Offer Letter

Norma Garcia, General Counsel

On October 13, 2024, we entered into an offer letter with Ms. Garcia (the “Garcia Offer Letter”) pursuant to which Ms. Garcia is entitled to receive (i) an annual base salary of $265,000 which will increase to $300,000 following completion of 12 months of continuous employment, (ii) Stock Options to purchase up to 400,000 Common Shares (iii) an award of 100,000 RSUs and (iv) a discretionary performance bonus to be determined by the CEO and the Board.

Termination and Change of Control Benefits. Under the Garcia Offer Letter, in the event that Ms. Garcia’s employment is terminated by the Company without cause or by Ms. Garcia for good reason following a change in control event, Ms. Garcia will be entitled to (i) her then base salary for 12 months to be paid in periodic installments in accordance with the Company’s customary payroll, (ii) acceleration of vesting of all Stock Options granted to Ms. Garcia and (iii) a continuation of all medical, dental and retirement plans including 401k plan for a period of 12 months following her termination.

Termination and Change of Control Benefits

As of March 31, 2026, Mr. Mills, Mr. Rutledge, Mr. Galloway, Dr. Burba, and Ms. Garcia were the only NEOs who had an effective employment agreement or offer letter with the Company. The effective dates, entitlements upon a termination without cause or by the executive for good reason and termination following a change of control pursuant to such employment agreement, offer letter or in the case of Ms. Jancik, the Jancik Severance Agreement are as described above under the agreement with each executive.

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth outstanding equity awards for the NEOs as of the end of the fiscal year ended March 31, 2026.

Incentive Plan Awards – Value Vested or Earned during the Year

The following table sets forth the value vested or earned during the year of option-based awards, share-based awards and non-equity incentive plan compensation paid to NEO during the financial year ended March 31, 2026 and is presented to comply with Canadian securities laws.

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

The following table summarizes the equity compensation plans under which our equity securities are authorized for issuance as of March 31, 2026.

DIRECTOR COMPENSATION

The form and amount of director compensation is reviewed annually and as deemed advisable by the Corporate Governance, Nominating and Compensation Committee (“CGNC Committee”), which shall make recommendations to the Board based on such review. The CGNC Committee reviews director compensation on an annual basis to ensure that we offer director compensation that is: (i) commensurate with the efforts we expect from existing Board members; (ii) competitive in the Company’s industry in order that we might attract the best possible candidates to assist we and its shareholders in a fiduciary capacity to maximize the opportunity presented by that growth; and (iii) aligned with shareholder interests as we grows. The Board retains the ultimate authority to determine the form and amount of director compensation.

The chart below outlines the Company’s current director compensation program for its non-employee directors:

In addition, each member of the Board of Directors is entitled to reimbursement for reasonable travel and other expenses incurred in connection with attending Board meetings and meetings for any committee on which he or she serves.

The following table sets forth all compensation paid to or earned by each director during the fiscal year ended March 31, 2026, other than Mr. Mills and Dr. Burba whose compensation is set forth above in the Summary Compensation Table.

Outstanding Share-Based Awards and Option-Based Awards

The following table sets forth all of the Options granted to the directors of the Company, not including those directors who were also NEOs, to purchase or acquire securities of the Company that were outstanding at the end of the financial year ended March 31, 2026 ($ are in United States dollars, unless otherwise noted).

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth the beneficial ownership of the Common Shares as of the Record Date, for (i) each member of the Board of Directors, (ii) each of our named executive officers (“NEO”), (iii) each person known to us to be the beneficial owner of more than 5% of the Company’s securities and (iv) the members of the Board and the executive officers as a group. The percentage ownership of Common Shares is based on 296,803,677 Common Shares outstanding as of the Record Date.

The table below sets forth (1) the number of Common Shares and the percentage of outstanding shares held as of the Record Date, as required by the Canadian securities laws and (2) the number of Common Shares and the percentage of outstanding shares beneficially held, calculated in accordance with SEC rules which takes into account Common Shares which the individual has or shares voting and/or investment power as well as Common Shares that may be acquired within 60 days (such as by exercising vested stock options). Including those shares in the tables does not, however, constitute an admission that the named shareholder is a direct or indirect beneficial owner of those shares. Unless otherwise indicated, each person or entity named in the table has sole voting power and investment power (or shares that power with that person’s spouse) with respect to all Common Shares listed as owned by that person or entity, subject to applicable community property laws.

# Amount of shares beneficially held and percentage includes Common Shares that such person has or shares voting power or investment power (directly or indirectly) and as to which such person has the right to acquire voting or investment power within 60 days.

* Represents less than 1% issued and outstanding Common Shares.

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

We describe below transactions or series of similar transactions, since April 1, 2022, or currently proposed, to which we were a party or will be a party, in which, the amounts involved exceeded $120,000 or 1% of the Company’s average total assets at year-end for the last two fiscal years, whichever is less, and in which any of our directors, executive officers or beneficial holders of more than 5% of any class of our capital stock, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest.

We recognize that transactions between us and any of our directors or executives or with a third party in which one of our officers, directors or significant shareholders has an interest can present potential or actual conflicts of interest and create the appearance that our decisions are based on considerations other than the best interests of us and our shareholders.

On March 4, 2018, we entered into a Royalty Agreement (“Royalty Agreement”) with NAL. The Royalty Agreement was entered into in connection with the acquisition by the Company of all of NAL’s data, analysis and reports related to lithium extraction from oilfield brines for petrol-lithium extraction projects. Pursuant to the Royalty Agreement, the Company agreed to pay to NAL on a fiscal quarterly basis a royalty equal to 5% of the Company’s “Product Income”, which is defined in the agreement as “the proceeds received by the Company from the sale of any Products less the Production Costs incurred by the Company.” The Royalty Agreement defines Products as “any saleable material.” The royalty may be paid at the election of NAL in cash, issuance of Common Shares or any combination of both. Based on the Company’s current business model, the Company does not anticipate selling any “Products” in the foreseeable future but rather leasing the MDLE Plants, which would generate lease revenue, and operating and maintaining the MDLE Plant, which would generate services revenue. The controlling shareholder of NAL is Dr. John Burba, the Company’s Chief Technology Officer. However, Dr. Burba was not at the time of entering into the Royalty Agreement, a related party.

On November 7, 2018, we entered into a licensing agreement with (i) Ensorcia Metals, a British Virgin Islands corporation and (ii) Sorcia Minerals, a Delaware limited liability company, controlled by Ensorcia Metals which provided to Sorcia Minerals, exclusive limited license to the Company’s technology in Chile and Argentina (Ensorcia Metals and Sorcia Minerals are collectively referred to as “Ensorcia” and the agreement is referred to as the “Ensorcia Licensing Agreement”). The controlling shareholder of Ensorcia is Mr. Daniel Layton, a former member of our Board who held in excess of 10% of our Common Shares at the time of the transaction (who now holds approximately 8.7% of our Common Shares). The Ensorcia Licensing Agreement provide Ensorcia the exclusive rights to market and develop the Company’s technology in Chile and Argentina provided that an MDLE Plant is installed and operational no later than December 31, 2028. The Ensorica Licensing Agreement provide Ensorcia the right to use the Company’s technology but does not transfer any ownership to Ensorcia. As consideration for us providing technology, know-how, design, construction, installation, operation of the MDLE Plant and making certain technical employees available, the Ensorica Licensing Agreement provides that we are entitled to a 6% royalty based on net sales, and a 10% equity interest in each project, as defined under the Ensorcia Licensing Agreements. The Ensorcia Licensing Agreements include other customary terms and conditions.

On February 19, 2021, the Company entered into a private placement transaction wherein the Company agreed to issue up to 17,250,000 units to each of Sorcia Minerals and EVL Holdings, with each unit comprised of one Common Share and one Warrant (the “2021 Private Placement”). The controlling shareholder of Sorcia Minerals is Mr. Daniel Layton, who is a greater than 5% shareholder and is a former member of our Board of Directors. Sorcia Minerals and EVL Holdings is a greater than 5% shareholder.

On March 30, 2023, we entered into a licensing agreement with Entec LLC (“Entec”), a Delaware limited liability company controlled by Mr. Daniel Layton, a former member of our Board, and a controlling shareholder of Entec, who owns approximately 12.9% of our Common Shares (the “Entec Licensing Agreement”). The Entec Licensing Agreement provides Entec, a non-exclusive, world-wide license (except Argentina and Chile) to access all patents, trade secrets, and other proprietary rights (“IP Rights”) for use by Entec solely for the purposes of (i) extracting lithium salts from brine and (ii) for the production and sale of products using the Company’s patented extraction systems licensed under the Entec Licensing Agreement. In consideration for receiving the IP Rights, Entec agreed to provide us with a royalty equal to 6% of the net sales, as defined under the Entec Licensing Agreement, with

respect to the first resource project or lithium extraction facility utilizing the Company’s licensed technology as well as an interest in the underlying project equal to 10% of Entec’s interest in the same project. The Entec Licensing Agreement allows Entec to sub-license the IP Rights to affiliates of Entec without written consent from the Company.

On April 21, 2023, we completed a non-brokered private placement (“April 2023 Placement”) and issued 6,396,999 Units, consisting of 6,396,999 Common Shares and 6,396,999 Warrants (“April 2023 Warrants”) to Encompass, an accredited investor, in reliance on Regulation S of the Securities Act, with each Unit being priced at CAD$1.04635 per share for gross

proceeds of $5.0 million. Each unit is comprised of one Common Share and one Warrant entitling the holder to purchase one Common Share for a period of two years at an exercise price of CAD$1.21. The proceeds from the private placement were used for working capital needs, to accelerate research and development efforts, product development and technology adoption, and for preplacement orders of MDLE Plants for sitting on customer brine resources.

On December 8, 2023, we entered into a transaction, whereby Mr. Garry Flowers, former Chief Executive Officer, Dr. John Burba, current Chief Technology Officer and Director, and an outside consultant subscribed for an aggregate of 1,629,838 units, with each unit comprised of one Common Share and one Warrant, for an aggregate amount of US$840,000.

On December 29, 2023, we entered into a transaction, whereby we agreed to issue 2,694,804 units, with each unit comprised of one Common Share and one Warrant to certain investors, including Douglas Smith, current Chief Financial Officer of the Company for gross proceeds of approximately $1.4 million. Pursuant to the private placement, Mr. Smith subscribed for 190,443 units for an aggregate subscription price of US$100,000.

On February 11, 2024, we entered into a binding term sheet with EV Metals VI, a private company controlled by Mr. Jacob Warnock, a current director of ours pursuant to which EV Metals VI agreed to subscribe for units for aggregate consideration of up to US$20 million (the “Term Sheet”). Below is a summary of the various transactions that have occurred to date pursuant to the Term Sheet:

On February 28, 2025, the Company entered the 2025 Letter Agreement (the “2025 Letter Agreement”) with EV Metals, a company controlled by Jacob Warnock, a director of the Company, agreeing to the principal terms and conditions upon which EV Metals, directly or through one or more of its subsidiaries or affiliates, has the option but not the obligation to purchase, in one or more transactions, up to $15.0 million of units (the “2025 EV Metals Offering”), which each unit (the “2025 EV Metals Units”) consisting of one Common Share and one warrant to purchase a Common Share.

On March 2, 2025, two entities controlled by EV Metals, EV Metals 7 LLC and EV Metals VI LLC, entered into binding subscription agreements for the purchase of a portion of the 2025 EV Metals Units. The first issuance under the 2025 Letter Agreement occurred on March 31, 2025 for gross proceeds of $7.55 million and the second issuance under the 2025 Letter Agreement occurred on April 11, 2025 for gross proceeds of $679,000. In connection with the two issuances, EV Metals 7 LLC acquired a total of 27,739,348 2025 EV Metals Units (25,393,475 in the first issuance and 2,345,873 in the second issuance) and EV Metals VI LLC acquired 690,979 2025 EV Metal Units. The pricing of the first and second issuance of the 2025 EV Metals Units was CAD$0.4168 per unit (USD$0.2894 per unit). Each warrant issued in the first and second issuance entitles the holder to purchase one Common Share at a price of CAD$0.51.

On October 30, 2025, the Company and EV Metals came to an agreement for a third issuance under the 2025 Letter Agreement for EV Metals to acquire an additional 12,464,000 2025 EV Metals Units priced at $0.16 per unit (CAD$0.255) for gross proceeds to the Company of $2.0 million. Each warrant issued in the third issuance entitles the holder to purchase one Common Share at a price of CAD$0.30.

On February 23, 2026, the Company and EV Metals 9 LLC (“EV Metals 9”), a company controlled by Jacob Warnock, a director of the Company, came to an agreement for a fourth issuances under the 2025 EV Metals Letter Agreement for EV Metals 9 to purchase 26,427,053 units ("EV Metals 9 Offering") priced at $0.08 per unit (CAD$0.104) for gross proceeds to the Company of $2.0 million. Each Warrant, issued in the fourth issuance entitles the holder to purchase one Common Share at a price of CAD$0.14.

On April 29, 2026, the Company and EV Metals 9 came to an agreement for the fifth issuance under the 2025 EV Metals Letter Agreement for EV Metals 9 to purchase 34,315,465 units priced at $0.08 per unit (CAD$0.109) for gross proceeds to the Company of $2.8 million. Each Warrant issued in the fifth issuance, entitles the holder to purchase one Common Share at a price of CAD$0.148.

The pricing of the 2025 EV Metals Units in each of the five issuances under the 2025 Letter Agreement was based on the five-day trading average of the Common Shares on the TSXV for the applicable tranche less a discount of 25% (the maximum allowable discount permitted by the rules of the TSXV). The warrants included in the 2025 EV Metals Units will have a term of four years from date of issuance and will entitle the holders to purchase a Common Share at an exercise price equal to the closing price of the Common Shares on the TSXV as of the date immediately preceding the date of the news release announcing the respective issuance of the 2025 EV Metals Offering. In connection with the each issuance of the 2025 EV Metals Units, the Company paid structuring fees of 5% of the gross proceeds to Mr. Warnock, for an aggregate of $0.8 million. Upon the fifth issuance, all amounts issuable under the 2025 Letter Agreement have been issued.

In connection with the 2025 EV Metals Offering, on March 31, 2025, we entered into an amendment (the “IRA Amendment”) to the investor rights agreement dated February 23, 2024 between the Company and EV Metals, which, among other things, previously granted EV Metals the right to appoint one director to the Company’s board of directors for as long as EV Metals and its affiliates maintained beneficial ownership of at least 5% of the issued and outstanding Common Shares and so long as the board of directors is comprised of five or less individuals. EV Metals initial nominee to the Company’s board of directors was Jacob Warnock. The IRA Amendment grants EV Metals the right to approve, in its sole discretion, the appointment of one additional individual to the Company’s board of directors so long as the board of directors is comprised of more than five individuals, provided that the additional appointee is independent of EV Metals and IBAT. Such nomination right will continue for as long as EV Metals and its affiliates maintain beneficial ownership of at least 5% of the issued and outstanding Common Shares.

On July 20, 2025, the Company entered into the Encompass Subscription Agreements with Encompass, a beneficial owner of more than 5% of the Company’s securities, for the purchase of up to 25,765,259 units at a price of CAD $0.26625 per unit (USD$0.19406 per unit). Each 2025 Encompass Unit consists of one Common Share and one warrant, with each warrant entitling the holder to purchase one additional Common Share for a period of three years from the closing date of the 2025 Encompass Offering at an exercise price of CAD$0.355 per share. In addition, the Company has agreed to grant Encompass the right but not the obligation to purchase up to $2.0 million additional units of the Company at any time on or before December 31, 2025. The closing of the 2025 Encompass Offering occurred on August 5, 2025, for gross proceeds to the Company of $5.0 million.

On July 20, 2025, the Company entered into amended and restated registration rights agreements (“A&R Registration Rights Agreements”) which amended the Registration Rights Agreements with each of EV Metals and Encompass. Pursuant to the A&R Registration Rights Agreements, we have agreed to use our reasonable best efforts to cause this Registration Statement to be declared effective as promptly as reasonably practicable but in no event later than July 20, 2026. In addition, pursuant to the Encompass A&R Registration Rights Agreement, upon the closing of the 2025 Encompass Offering we have agreed that, upon request of Encompass, we will use our commercially reasonable efforts to (i) file a registration statement registering the Common Shares to be issued at closing of the 2025

Encompass Offering, including the Common Shares issuable upon exercise of the warrants which form a part of the 2025 Encompass Units within 90 days and (ii) have such registration statement declared effective as promptly as reasonably

practicable following the filing thereof but in no event later than 60 days if the registration statement is not reviewed by the SEC or 180 days if subject to review. The A&R Registration Rights Agreements provide that, subject to certain requirements and customary conditions, each of EV Metals and Encompass will have “piggy-back” registration rights with respect to underwritten offerings by us and other shareholders. In addition, upon the request of EV Metals, we have agreed to take necessary steps to facilitate up to two underwritten offerings which must occur prior to the third anniversary of the effective date of this registration statement on Form S-1; provided that the aggregate price of such offering is expected to be $25 million or less.

The A&R Registration Rights Agreements contain customary cross-indemnification provisions, under which we are obligated to indemnify the selling shareholders in the event of material misstatements or omissions in the registration statement and any violation or alleged violation by us of the Securities Act, Exchange Act, or any state securities law, or any rule or regulation thereunder, and the selling shareholders are obligated to indemnify us for material misstatements or omissions attributable to them. We will generally pay all registration expenses in connection with our obligations under the A&R Registration Rights Agreements, regardless of whether any our Common Shares are sold pursuant to a registration statement.

In connection of the foregoing, pursuant to the A&R Registration Rights Agreements, we agreed to to extend the expiration date of the warrants previously issued to Encompass and EV Metals pursuant to the private placements which occurred on April 21, 2023, February 29, 2024, May 3, 2024, and June 19, 2024 to the earlier of (i) five years from the date of such warrants original issuance or (ii) three years from the date of the closing of the 2025 Encompass Offering (the “Warrant Amendments”) and each of EV Metals and Encompass has agreed to waive their respective rights to any possible claims, including the right to liquidation damages, under the Registration Rights Agreements provided that the Warrant Amendments are approved by the TSXV.

PROPOSAL 3 - APPROVAL OF A CONSOLIDATION (REVERSE STOCK SPLIT) OF THE
OUTSTANDING COMMON SHARES

At the Annual Meeting shareholders will be asked to consider and approve an ordinary or, if the Consolidation does not occur until after the Continuance has been effected, a special resolution resolution (the “Consolidation Resolution”) authorizing the Company to effect the consolidation of the Common Shares (the “Consolidation”) on the basis of one (1) post-consolidation common share for up to a maximum of every fifty (50) pre-consolidation Common Shares then issued and outstanding, or such other lesser number of pre-consolidation Common Shares as may be determined by the Board in its sole discretion. As of the record date, the Company has 296,803,677 Common Shares outstanding. The final basis of the Consolidation will be determined by the Board at the time of the Consolidation within the limits described above. In addition, notwithstanding approval of the proposed Consolidation Resolution by the shareholders, the Board, in its sole discretion, may revoke the ordinary resolution, and abandon the Consolidation without further approval or action by, or prior notice to, the shareholders.

The Company wishes to reduce the amount of outstanding common share of the Company to keep in line with other listed issuers on the TSXV. The Company believes that if implemented, the Consolidation will promote increased liquidity and reduced volatility in the trading of its Common Shares. If approved and when implemented, the Consolidation will occur simultaneously for all of the Company's issued and outstanding Common Shares. The Consolidation will affect all holders of currently issued Common Shares uniformly and will not affect any shareholder’s percentage ownership interest in the Company, except to the extent that the Consolidation would otherwise result in a shareholder owning a fractional common share. No fractional post-Consolidation Common Shares will be issued and no cash will be paid in lieu of fractional post-Consolidation Common Shares. Any fractional Common Shares resulting from the Consolidation will be rounded to the nearest whole common share, as applicable.

Assuming completion of the Consolidation on a 50 for 1 basis, there will be approximately 5,936,074 Common Shares issued and outstanding.

Risks Associated with the Consolidation

There can be no assurance that the market price of our Common Shares will increase as a result of the Consolidation. The marketability and trading liquidity of our Common Shares may not improve. The Consolidation may result in some shareholders owning "odd lots" of less than 100 Common Shares, which may be more difficult for such shareholders to sell or which may require greater transaction costs per common share to sell.

Although approval for the Consolidation is being sought at the Annual Meeting, such a Consolidation would become effective at a date in the future in an amount of pre-consolidation Common Shares up to a maximum basis of 50 for 1 to be determined by the Board when the Board considers it to be in the best interests of the Company to implement such a Consolidation. The special resolution will also authorize the Board to elect not to proceed with, and abandon, the Consolidation at any time if it determines, in its sole discretion, to do so.

Principal Effects of the Consolidation

The principal effects of the Consolidation include the following:

Effect on Common Share Certificates

On the effective date of the Consolidation, the Company will instruct Computershare to issue and deliver share certificates or a DRS Advice (if available) representing post-consolidated Common Shares to the existing pre-consolidation

shareholders of the Company. No further action will be required by shareholders in order to receive the post-consolidated Common Shares other than certain registered shareholders holding share certificates who will be required to complete a letter of transmittal in a form to be provided at the time of the Consolidation. Following the effective date of the Consolidation, pre-consolidation Common Shares will be considered null and void.

Ordinary/Special Resolution

The shareholders will be asked to approve the Consolidation by passing at the Annual Meeting the Consolidation Resolution substantially in the form set forth below:

"BE IT RESOLVED AS AN ORDINARY/SPECIAL RESOLUTION THAT:

Required Vote and Board Recommendation

For the Consolidation to be completed prior to the Continuance, the Consolidation proposal must be passed by a majority of the votes cast (50% plus 1) with respect to the Consolidation Resolution by the shareholders of the Company present in person or by proxy at the Annual Meeting. However, for the Consolidation to be completed after the Continuance, the Consolidation must be passed by two-thirds (66 2/3%) of the votes cast. If the Consolidation is passed by at least a majority but by less than two-thirds of the votes cast, the Consolidation may only occur prior to the Continuance. Unless otherwise directed, management intends to vote such proxies in favor of the resolution approving the Consolidation.

The Board has reviewed the terms of the Consolidation and concluded that it is in the best interests of the Company to proceed with the Consolidation. The Board recommends that the shareholders vote “FOR” Proposal 3.

Irrespective of whether the Consolidation Resolution is passed by the shareholders of the Company, the majority of the Board may elect not to proceed with the Consolidation and the other transactions contemplated in the Consolidation Resolution.

PROPOSAL 4(a) and 4(b)

ADVANCE NOTICE AMENDMENT RESOLUTION OF ARTICLES FOR BRITISH COLUMBIA

At the Meeting, Shareholders will be asked to pass two special resolutions authorizing amendments to the Notice of Articles and Articles of the Company to: a) amend the Advance Notice Provision in Article 14.12 of the Articles, which we refer to as Proposal 4(a) - the Advance Notice Amendment Resolution, and b) alter the Company's authorized share capital to create (i) a voting class of an unlimited number of preferred shares without par value, issuable in series; and (ii) a non-voting class of an unlimited number of preferred shares without par value, issuable in series (collectively, the "Preferred Shares"); and amend the Articles and Notice of Articles of the Company attaching special rights and restrictions to the Common Shares and Preferred Shares, which we refer to as Proposal 4(b) - the Preferred Shares Amendment Resolution.

Proposal 4(a) - the Advance Notice Amendment Resolution

The amendments to Section 14.12 of the Articles, which implement advance notice provisions are being proposed to ensure that the Company is able to maintain compliance with U.S. securities laws now that it is subject to the U.S. securities laws. Specifically the Advance Notice Amendment Resolution stipulates that a Notice of Nominee sent by a Nominating Shareholder must be delivered (a) in the case of an annual meeting of shareholders, given not less than 90 nor more than 120 days prior to the first anniversary of the immediate preceding annual meeting of shareholders; provided, however, that in the event that no annual meeting of shareholders was held in the previous year or the annual meeting of shareholders is to be held on a date that is not within 30 days before or after such anniversary date, notice by the Nominating Shareholder may be made not later the close of business on the tenth (10th) day following the day on which the first public announcement (as defined below) of the date of the annual meeting of shareholders was made; and (b) in the case of a special general meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not called for other purposes), given not later than the close of business on the sixtieth (60th day prior to the date of the special meeting provided however, in the event that less than 70 days notice of the date of the special meeting of shareholders is given or made to shareholders, notice by the Nominating Shareholder must be made not later than the close of business on the tenth (10th) day following the day on which the first public announcement (as defined below) of the date of the special meeting of shareholders is made.

The current Articles provide that a Notice of Nominee must be sent by a Nominating Shareholder (a) in the case of an annual meeting of shareholders, given not less than 30 nor more than 65 days prior to the date of the annual meeting of shareholders; provided, however, that in the event that the annual meeting of shareholders is to be held on a date that is less than 50 days after the date (the “Notice Date”) on which the first public announcement of the date of the annual meeting was made, notice by the Nominating Shareholder may be made not later than the close of business on the tenth (10th) day following the Notice Date; and (b) in the case of a special general meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not called for other purposes), given not later than the close of business on the fifteenth (15th) day following the day on which the first public announcement of the date of the special general meeting of shareholders was made.

The Board is proposing adoption of the Advance Notice Amendment Resolution to facilitate compliance with the US federal securities laws which have notice and access deadlines and universal proxy provisions that make compliance with the current advance notice provisions difficult.

Proposal 4(b) - the Preferred Shares Amendment Resolution

The Board believes that the creation of the new classes of Preferred Shares, issuable in series (sometimes referred to as blank cheque preferred shares) will provide management with greater flexibility in raising capital for the Company. Specifically the Preferred Shares may be used by the Board for any appropriate corporate purpose, including, without limitation, as a means of obtaining additional capital for use in the Company's business and operations such as in the following types of transactions.

Attracting Strategic Investors: During certain capital raising transactions, such as Private Investments in Public Equity transactions (PIPEs) or capital-raising rounds in volatile markets, institutional investors or strategic partners may seek to invest

in securities with more downside protection than Common Stock. Preferred Shares would provide senior liquidation preference, fixed dividend yield, and conversion rights into Common Stock.

Balance Sheet and Credit Protection: The issuance of Preferred Shares could also allow a company to raise capital without increasing its debt load or incurring strict loan covenants. Rating agencies generally classify Preferred Shares as having equity-like characteristics, helping protect credit ratings and preserving future borrowing capacity.

Tailored Capital Structure: The Company would have the flexibility to issue convertible Preferred Shares as a hybrid instrument that offers investors yield protection while allowing the Company to limit dilution if its Common Stock price rises over time.

While there are no present plans or arrangements to use the Preferred Shares at this time, the Preferred Shares would permit the Board to negotiate with potential investors regarding the rights and preferences of a series of Preferred Shares that may be issued to meet market conditions and financing opportunities as they arise, without the expense or delay in connection with calling a Shareholders' meeting to approve specific terms of any class or series of Preferred Shares.

The Board will be empowered to fix the number of shares in each series of each class of the Preferred Shares and to attach special rights or restrictions to the shares of that series, before the issuance of shares of any particular series. The Board will have the authority to fix, among other things, the number of shares constituting any such series, the identifying name of the series, the voting rights in respect of the voting Preferred Shares, and other special rights or restrictions thereof, including the dividend rights and dividend rate, terms of redemption (including sinking fund provisions), redemption price or prices, conversion rights and liquidation rights of the shares constituting any series.

Possible Anti-Takeover Effects of the Proposed Preferred Shares Amendment Resolution

As stated above, in addition to the corporate purposes mentioned in this Proposal 4, the authority possessed by the Board to create and issue Preferred Shares could potentially be used to discourage attempts by others to obtain control of the Company through a merger, takeover bid offer, proxy contest or otherwise by making such attempts more difficult or costly to achieve. The Board has not proposed the Articles Amendment with the intention of discouraging take-over bids, proxy contests or other attempts to obtain control of the Company. Rather, the proposed Articles Amendment has been prompted by business and financial considerations, as set out above, and it is the intended purpose of the Articles Amendment to provide greater flexibility to the Board in considering and planning for our potential future corporate needs. However, as noted, the availability of Preferred Shares for issuance may have the effect of discouraging a merger, tender offer, proxy contest, or other attempt to obtain control of the Company. There are no plans or arrangements to use the Preferred Shares at the present time.

Additionally, the Board may issue Preferred Shares without Shareholder approval and with voting and conversion rights, which could adversely affect the voting power of Common Shares.

The full text of the proposed amendments to the Articles including the proposed changes to Section 14.2 of the Articles and the special rights and restrictions attaching to the Common Shares and the Preferred Shares is attached hereto as Schedule "B".

Special Resolutions

The shareholders will be asked to approve the Articles of Amendment by passing at the Annual Meeting each of the Advance Notice Amendment Resolution and the Preferred Share Amendment Resolution substantially in the forms set forth below:

Advance Notice Amendment Resolution

"BE IT RESOLVED AS A SPECIAL RESOLUTION THAT:

Preferred Share Amendment Resolution

"BE IT RESOLVED AS A SPECIAL RESOLUTION THAT:

Required Vote and Board Recommendation

Each of the two resolutions, Proposal 4(a) and Proposal 4(b) are separate votes and not contingent upon each other. To be effective each of the Proposal 4(a) and Proposal 4(b) must be passed by two-thirds (66 2/3%) of the votes cast. Unless otherwise directed, management intends to vote such proxies in favor of the resolution approving the Articles of Amendment.

The Board has reviewed the terms of the Articles of Amendment and concluded that it is in the best interests of the Company to proceed with the Articles of Amendment and implement both the Advance Notice Amendment Resolution and the Preferred Shares Amendment Resolution. The Board recommends that the shareholders vote “FOR” each of Proposal 4(a) and Proposal 4(b).

Irrespective of whether the Preferred Shares Amendment Resolution is passed by the shareholders of the Company, the majority of the Board may elect not to proceed with the Articles of Amendment with respect to the creation of the Preferred Shares.

PROPOSAL 5

CONTINUANCE INTO ONTARIO

The Company is currently governed by the Business Corporations Act (British Columbia) (the "BCBCA"). Management is seeking the approval of shareholders, by special resolution, to continue the Company into the Province of Ontario pursuant to Section 180 of the Business Corporations Act (Ontario) (the "OBCA") (the "Continuance"). The Continuance will be effective upon approval of the articles of continuance (the "Articles of Continuance") to be filed with the Director (appointed under Section 278 of the OBCA (the "Director")) pursuant to subsection 180(2) of the OBCA after the B.C. Registrar of Companies (appointed under Section 400 of the BCBCA (the "Registrar")) has granted to the Company an authorization to continue into the Province of Ontario.

As the Company's principal executive offices and management are now located in Texas, and the Company's operations are primarily focused in the United States, management believes that it will be more efficient and cost effective for the Company to be governed by the laws of Ontario.

Upon completion of the Continuance, the BCBCA will cease to apply to the Company and the Company will become subject to the OBCA, as if it had been originally incorporated as an Ontario company. The Continuance will not result in any change in the name or business of the Company or its assets, liabilities or net worth.

If the special resolution approving the Continuance (the “Continuance Resolution”) is approved at the Meeting, it is proposed the Company shall apply to and file all necessary documentation with the Registrar under the BCBCA for an authorization to continue into the Province of Ontario. Immediately following the receipt of the Registrar’s authorization, it is proposed that the Company shall apply for a certificate of continuance and file Articles of Continuance under the OBCA to continue the Company into Ontario. The Articles of Continuance will constitute the governing instrument of the continued company under the OBCA and the certificate of continuance issued by the Director will be deemed to be the certificate of incorporation of the continued company (the “New Articles”).

The New Articles and new by-laws of the Company (the “New By-laws”) are expected to be substantially in the form attached to this Information Circular/Proxy Statement as Appendix “C” and Appendix “D”, respectively.

In order to complete the Continuance, shareholders will be asked, at the Annual Meeting, to consider, and if thought advisable, to pass, with or without amendment, the Continuance Resolution as more particularly set out below. The Continuance Resolution must be passed by not less than 66 2/3% of the votes cast by the shareholders present in person or represented by proxy at the Annual Meeting. Management recommends that shareholders vote in favor of the Continuance Resolution.

Section 309 of the BCBCA gives to registered shareholders who object to the Continuance the right of dissent provided under section 238 of the BCBCA under Division 2 of Part 8 in respect of the Continuance and to be paid the fair value of their Common Shares determined as of the day before the resolution approving the Continuance was passed. See "Dissent Right to Continuance" below for details of this dissent right.

Comparison of Rights Under the OBCA and the BCBCA

The OBCA provides shareholders with substantially the same rights as are available to shareholders under the BCBCA, including rights of dissent and appraisal and rights to bring derivative actions and oppression actions. However, there are certain differences between the two statutes and the regulations made thereunder.

The following is a summary of certain differences between the BCBCA and the OBCA, but it is not intended to be a comprehensive review of the two statutes. Reference should be made to the full text of both statutes and the regulations thereunder for particulars of any differences between them, and shareholders should consult their own legal or other professional advisors with regard to all of the implications of the Continuance which may be of importance to them.

Sale of Business or Assets

Under the BCBCA, the directors of a corporation may sell, lease or otherwise dispose of all or substantially all of the undertaking of the corporation only if it is in the ordinary course of the corporation's business or with shareholder approval authorized by special resolution. Under the BCBCA, a special resolution requires the approval of a "special majority", which

means the majority specified in a corporation's articles, if such specified majority is at least two-thirds and not more than three-quarters of the votes cast by those shareholders voting in person or by proxy at a general meeting of the corporation. If the articles do not contain a provision stipulating the special majority, then a special resolution is passed by at least two-thirds of the votes cast on the resolution.

The OBCA requires approval of the holders of two-thirds of the shares of a corporation represented at a duly called meeting to approve a sale, lease or exchange of all or substantially all of the property of the corporation that is other than in the ordinary course of business of the corporation. Holders of shares of a class or series, whether or not they are otherwise entitled to vote, can vote separately only if that class or series is affected by the sale, lease or exchange in a manner different from the shares of another class or series.

Amendments to the Charter Documents of a Company

Changes to the articles of a corporation under the BCBCA will be effected by the type of resolution specified in the articles of a corporation, which, for many alterations, including change of name or alterations to the articles, could provide for approval solely by a resolution of the directors. In the absence of anything in the articles, most corporate alterations will require a special resolution of the shareholders to be approved by not less than two-thirds of the votes cast by the shareholders voting on the resolution. Alteration of the special rights and restrictions attached to issued shares requires, subject to the requirements set forth in the corporation's articles, consent by a special resolution of the holders of the class or series of shares affected. A proposed amalgamation or continuation of a corporation out of the jurisdiction generally requires shareholders to approve the adoption of the amalgamation agreement or the continuance, as applicable, by way of a special resolution.

Under the OBCA, certain amendments to the charter documents of a corporation require a resolution passed by not less than two-thirds of the votes cast by the shareholders voting on the resolution authorizing the amendments and, where certain specified rights of the holders of a class or series of shares are affected by the amendments differently than the rights of the holders of other classes or series of shares, such holders are entitled to vote separately as a class or series, whether or not such class or series of shares otherwise carry the right to vote. A resolution to amalgamate an OBCA corporation requires a special resolution passed by the holders of each class or series of shares, whether or not such shares otherwise carry the right to vote, if such class or series of shares are affected differently.

Rights of Dissent and Appraisal

The BCBCA provides that shareholders, including beneficial holders, who dissent from certain actions being taken by a corporation, may exercise a right of dissent and require the corporation to purchase the shares held by such shareholder at the fair value of such shares. The dissent right is applicable where the corporation proposes to: (a) alter the articles to alter restrictions on the powers of the corporation or on the business it is permitted to carry on; (b) adopt an amalgamation agreement; (c) approve an amalgamation under Division 4 of Part 9 of the BCBCA; (d) approve an arrangement, the terms of which arrangement permit dissent; (e) authorize or ratify the sale, lease or other disposition of all or substantially all of the corporation's undertaking; or (f) authorize the continuation of the corporation into a jurisdiction other than British Columbia.

Oppression Remedies

Under the OBCA a registered shareholder, beneficial shareholder, former registered shareholder or beneficial shareholder, director, former director, officer, former officer of a corporation or any of its affiliates, or any other person who, in the discretion of a court, is a proper person to seek an oppression remedy, and in the case of an offering corporation, the Ontario Securities Commission, may apply to a court for an order to rectify the matters complained of where in respect of a corporation or any of its affiliates: (a) any act or omission of the corporation or any of its affiliates effects or threatens to effect a result; (b) the business or affairs of the corporation or any of its affiliates are, have been or are threatened to be carried on or conducted in a manner; or (c) the powers of the directors of the corporation or any of its affiliates are, have been or are threatened to be exercised in a manner, that is oppressive or unfairly prejudicial to, or that unfairly disregards the interests of, any security holder, creditor, director or officer.

The oppression remedy under the BCBCA is similar to the remedy found in the OBCA, with a few differences. Under the OBCA, the applicant can complain not only about acts of the corporation and its directors but also acts of an affiliate of the corporation and the affiliate's directors, whereas under the BCBCA, the shareholder can only complain of oppressive conduct of the corporation. Under the BCBCA the applicant must bring the application in a timely manner, which is not required under the OBCA, and the court may make an order in respect of the complaint if it is satisfied that the application was brought by the shareholder in a timely manner. As with the OBCA, the court may make such order as it sees fit, including an order to prohibit

any act proposed by the corporation. Under the OBCA a corporation is prohibited from making a payment to a successful applicant in an oppression claim if there are reasonable grounds for believing that (a) the corporation is, or after the payment, would be unable to pay its liabilities as they become due, or (b) the realization value of the corporation's assets would thereby be less than the aggregate of its liabilities; under the BCBCA, if there are reasonable grounds for believing that the corporation is, or after a payment to a successful applicant in an oppression claim would be, unable to pay its debts as they become due in the ordinary course of business, the corporation must make as much of the payment as possible and pay the balance when the corporation is able to do so.

Derivative Actions

A broader right to bring a derivative action is contained in the OBCA than is found in the BCBCA, and this right extends to former shareholders, directors or officers of a corporation or its affiliates, and any person who, in the discretion of the court, is a proper person to make an application to court to bring a derivative action. In addition, the OBCA permits derivative actions to be commenced in the name and on behalf of a corporation or any of its subsidiaries. The complainant must provide the directors of the corporation or its subsidiary with fourteen days' notice of the complainant's intention to apply to the court to bring a derivative action, unless all of the directors of the corporation or its subsidiary are defendants in the action.

Requisition of Meetings

The BCBCA provides that one or more shareholders of a corporation holding not less than 5% of the issued voting shares of the corporation may give notice to the directors requiring them to call and hold a general meeting which meeting must be held within 4 months. Subject to certain exceptions, if the directors fail to provide notice of a meeting within 21 days of receiving the requisition, the requisitioning shareholders, or any one or more of them holding more than 2.5% of the issued shares of the corporation that carry the right to vote at general meetings may send notice of a general meeting to be held to transact the business stated in the requisition.

The OBCA permits the holders of not less than 5% of the issued shares of a corporation that carry the right to vote to require the directors to call and hold a meeting of the shareholders of the corporation for the purposes stated in the requisition. Subject to certain exceptions, if the directors fail to provide notice of a meeting within 21 days of receiving the requisition, any shareholder who signed the requisition may call the meeting.

Place of Shareholders' Meetings

The BCBCA requires all meetings of shareholders to be held in British Columbia unless: (i) a location outside the province of British Columbia is provided for in the articles; (ii) the articles do not restrict the corporation from approving a location outside of the province of British Columbia for holding of the general meeting and the location of the meeting is approved by the resolution required by the articles for that purpose or by ordinary resolution if no resolution is required for that purpose by the articles; or (iii) if the location for the meeting is approved in writing by the registrar before the meeting is held.

The OBCA provides that, subject to the articles and any unanimous shareholder agreement, meetings of shareholders may be held either inside or outside Ontario as the directors may determine, or in the absence of such a determination, at the place where the registered office of the corporation is located.

Directors' Residency Requirements

The BCBCA provides that a public corporation must have at least three directors but does not have any residency requirements for directors.

The OBCA provides that a public corporation must have at least three directors but does not have any residency requirements for directors.

Removal of Directors

The BCBCA provides that the shareholders of a corporation may remove one or more directors by a special resolution or by any other method specified in the articles. If holders of a class or series of shares have the exclusive right to elect or appoint one or more directors, a director so elected or appointed may only be removed by a separate special resolution of the shareholders of that class or series or by any other method specified in the articles.

The OBCA provides that the shareholders of a corporation may by ordinary resolution at an annual or special meeting remove any director or directors from office. An ordinary resolution under the OBCA requires the resolution to be passed, with or without amendment, at the meeting by at least a majority of the votes cast. The OBCA further provides that where the holders of any class or series of shares of a corporation have an exclusive right to elect one or more directors, a director so elected may only be removed by an ordinary resolution at a meeting of the shareholders of that class or series.

Meaning of "Insolvent"

Under the BCBCA, for purposes of the insolvency test that must be passed for the payment of dividends and purchases and redemptions of shares, "insolvent" is defined to mean when a corporation is unable to pay its debts as they become due in the ordinary course of its business. Unlike the OBCA, the BCBCA does not impose a net asset solvency test for these purposes. For purposes of proceedings to dissolve or liquidate, the definition of "insolvent" from federal bankruptcy legislation applies.

Under the OBCA, a corporation may not pay dividends or purchase or redeem its shares if there are reasonable grounds for believing (i) it is or would be unable to pay its liabilities as they become due; or (ii) it would not meet a net asset solvency test. The net asset solvency tests for different purposes vary somewhat.

Reduction of Capital

Under the BCBCA, capital may be reduced by special resolution or court order. A court order is required if the realizable value of the corporation's assets would, after the reduction of capital, be less than the aggregate of its liabilities.

Under the OBCA, capital may be reduced by special resolution but not if there are reasonable grounds for believing that, after the reduction, (i) the corporation would be unable to pay its liabilities as they become due; or (ii) the realizable value of the corporation's assets would be less than its liabilities.

Shareholder Proposals

The BCBCA includes a more detailed regime for shareholders' proposals than the OBCA. For example, a person submitting a proposal must have been the registered or beneficial owner of one or more voting shares for at least two years before signing the proposal. In addition, the proposal must be signed by shareholders who, together with the submitter, are registered or beneficial owners of (i) at least 1% of the corporation's voting shares, or (ii) shares with a fair market value exceeding an amount prescribed by regulation (at present, C$2,000).

The OBCA allows shareholders entitled to vote or a beneficial owner of shares that are entitled to be voted to submit a notice of a proposal.

Compulsory Acquisition

The OBCA provides a right of compulsory acquisition for an offeror that acquires 90% of the target securities pursuant to a take-over bid or issuer bid, other than securities held at the date of the bid by or on behalf of the offeror.

Investigation/Appointment of Inspectors

Under the BCBCA, a corporation may appoint an inspector by special resolution. Shareholders holding at least 20% of the issued shares of a corporation may apply to the court for the appointment of an inspector. The court must consider whether there are reasonable grounds for believing there has been oppressive, unfairly prejudicial, fraudulent, unlawful or dishonest conduct.

Under the OBCA, shareholders can apply to the court for the appointment of an inspector. Unlike the BCBCA, the OBCA does not require an applicant to hold a specified number of shares.

Shareholders will be asked at the Annual Meeting to consider, and, if thought appropriate, to pass, with or without variation, the following special resolution:

Special Resolution

The shareholders will be asked to approve the Continuance by passing at the Annual Meeting the Continuance Resolution substantially in the form set forth below:

"BE IT HEREBY RESOLVED AS A SPECIAL RESOLUTION OF INTERNATIONAL BATTERY METALS LTD. (THE "COMPANY") THAT:

Required Vote and Board Recommendation

To be effective, the Continuance Resolution must be passed by two-thirds (66 2/3%) of the votes cast. Unless otherwise directed, management intends to vote such proxies in favor of the resolution approving the Continuance.

The Board has reviewed the terms of the Continuance and concluded that it is in the best interests of the Company to proceed with the Continuance. The Board recommends that the shareholders vote “FOR” Proposal 5.

Irrespective of whether the Continuance Resolution is passed by the shareholders of the Company, the majority of the Board may elect not to proceed with the Continuance.

Section 309 of the BCBCA gives to registered shareholders who object to the Continuance the right of dissent provided under section 238 of the BCBCA under Division 2 of Part 8 in respect of the Continuance and to be paid the fair value of their Common Shares determined as of the day before the resolution approving the Continuance was passed. See "Dissent Right to the Continuance" below for details of this dissent right.

Dissent Right to the Continuance

The following is only a summary of the dissent rights applicable to the Continuance under the Dissent Provisions, which are technical and complex. The summary is not a comprehensive statement of the procedures to be followed by a shareholder who seeks to exercise the Dissent Rights and is qualified in its entirety by the complete text of the Dissent Provisions, which are attached to this Information Circular/Proxy Statement as Schedule “[E]”. A shareholder who intends to exercise Dissent Rights in respect of the Continuance Resolution should carefully review, consider and comply with the Dissent Provisions. Additionally, persons who are beneficial owners of shares registered in the name of a broker, custodian, nominee or other intermediary, or in some other name, should contact the registered shareholder for assistance in exercising the Dissent Rights.

Division 2 of Part 8 of the BCBCA (the “Dissent Provisions”) provides that a shareholder of the Company, whether or not such shareholder’s shares carry the right to vote, has the right to dissent from the Continuance Resolution (“Dissent Rights”). A shareholder who validly exercises the Dissent Rights, in accordance with the Dissent Provisions, will be entitled, if the Continuance is completed, to be paid the payout value of the dissenting shareholder’s Common Shares determined in accordance with the Dissent Provisions.

A shareholder who wishes to exercise the Dissent Rights must give written notice of dissent (a “Dissent Notice”) to the Company by depositing the Dissent Notice with the Company, or by mailing it to the Company by registered mail at 12 Greenway Plaza, Suite 1100, Houston, Texas 77046, marked to the attention of the Corporate Secretary, not later than two business days before the Annual Meeting. A shareholder who wishes to exercise the Dissent Rights must prepare a separate Dissent Notice for: (i) the shareholder, if the shareholder is dissenting on its own behalf, and (ii) each person who beneficially owns Common Shares in the shareholder’s name and on whose behalf the shareholder is dissenting. To be valid, a Dissent Notice must:

(a) identify in each Dissent Notice the person on whose behalf dissent is being exercised;

(b) set out the number of Common Shares in respect of which the shareholder is exercising the Dissent Rights (the “Notice Shares”), which number cannot be less than all of the Common Shares held by a beneficial owner on whose behalf the Dissent Rights are being exercised, if any;

(c) if the Notice Shares constitute all of the Common Shares of which the dissenting shareholder is both the registered owner and beneficial owner and the dissenting shareholder owns no other Common Shares as beneficial owner, a statement to that effect;

(d) if the Notice Shares constitute all of the Common Shares of which the dissenting shareholder is both the registered and beneficial owner but the dissenting shareholder owns other shares of the Company as beneficial owner, a statement to that effect, and (i) the names of the registered owners of those other shares, (ii) the number of those other shares that are held by each of those registered owners, and (iii) a statement that Notices of Dissent are being or have been sent in respect of all those other shares; and

(e) if dissent is being exercised by the shareholder on behalf of a beneficial owner who is not the dissenting shareholder, a statement to that effect and the name of the beneficial owner, and the dissenting shareholder must dissent with respect to all of the Common Shares, registered in the shareholder’s name, of which the beneficial owner is the beneficial owner.

The giving of a Dissent Notice does not deprive a dissenting shareholder of the shareholder’s right to vote at the Annual Meeting, however, a shareholder is not entitled to exercise the Dissent Rights with respect to any Common Shares if the shareholder votes (or instructs or is deemed, by submission of an incomplete proxy or otherwise, to have instructed the shareholder’s proxyholder to vote) in favour of the Continuance Resolution. A vote against the Continuance Resolution or the execution or exercise of a proxy does not constitute a Dissent Notice. A dissenting shareholder, however, may vote as a proxy for a shareholder whose proxy required an affirmative vote, without affecting the shareholder’s right to exercise the Dissent Rights. If the Company intends to act on the authority of the Continuance Resolution, it must send a notice (the “Notice to Proceed”) to the dissenting shareholder promptly after the later of:

(a) the date on which the Company forms the intention to proceed with the Continuance; and

(b) the date on which the Dissent Notice was received.

If the Company has acted on the Continuance Resolution it must promptly send a Notice to Proceed to the dissenting shareholder. The Notice to Proceed must be dated not earlier than the date on which it is sent and state that the Company intends to act or has acted on the authority of the Continuance Resolution and advise the dissenting shareholder of the manner in which dissent is to be completed. On receiving a Notice to Proceed, the dissenting shareholder is entitled to require the Company to purchase all of the Common Shares in respect of which the Dissent Notice was given.

A dissenting shareholder who receives a Notice to Proceed, and who wishes to proceed with the dissent, must send to the Company or to the Transfer Agent within one month after the date of the Notice to Proceed:

(a) a written statement that the dissenting shareholder requires the Company to purchase all of the Notice Shares;

(b) the certificates, if any, representing the Notice Shares; and

(c) if dissent is being exercised by the shareholder on behalf of a beneficial owner who is not the dissenting shareholder, a written statement signed by the beneficial owner setting out whether the beneficial owner is the beneficial owner of other Common Shares and if so, setting out (i) the names of the registered owners of those other Common Shares, (ii) the number of those other Common Shares that are held by each of those registered owners, and (iii) that dissent is being exercised in respect of all of those other Common Shares, whereupon the Company is bound to purchase them in accordance with the Dissent Notice.

The Company and the dissenting shareholder may agree on the amount of the payout value of the Notice Shares and in that event, the Company must either promptly pay that amount to the dissenting shareholder or send a notice to the dissenting shareholder that the Company is unable lawfully to pay dissenting shareholders for their Common Shares as the Company is insolvent or the payment would render the Company insolvent. If the Company and the dissenting shareholder do not agree on the amount of the payout value of the Notice Shares, the dissenting shareholder or the Company may apply to the Supreme Court of British Columbia (the “Court”) and the Court may:

(a) determine the payout value of the Notice Shares or order that the payout value of the Notice Shares be established by arbitration or by reference to the registrar or a referee of the Court;

(b) join in the application each dissenting shareholder who has not agreed with the Company on the amount of the payout value of the Notice Shares; and

(c) make consequential orders and give directions it considers appropriate.

Promptly after a determination of the payout value of the Notice Shares has been made, the Company must either pay that amount to the dissenting shareholder or send a notice to the dissenting shareholder that the Company is unable lawfully to pay dissenting shareholders for their Common Shares as the Company is insolvent or the payment would render the Company insolvent. If the dissenting shareholder receives a notice that the Company is unable to lawfully pay dissenting shareholders for their Common Shares, the dissenting shareholder may, within 30 days after receipt, withdraw the shareholder’s Dissent Notice. If the Dissent Notice is not withdrawn, the dissenting shareholder remains a claimant against the Company to be paid as soon as the Company is lawfully able to do so or, in a liquidation, to be ranked subordinate to the rights of creditors of the Company but in priority to the shareholders.

A dissenting shareholder who:

(a) properly exercises the Dissent Rights by strictly complying with all of the Dissent Provisions required to be complied with by a dissenting shareholder, will cease to have any rights as a shareholder other than the right to be paid the fair value of such shareholder’s Common Shares in accordance with the Dissent Provisions; or

(b) seeks to exercise the Dissent Rights, but who for any reason does not properly comply with each of the Dissent Provisions required to be complied with by a dissenting shareholder loses such right to dissent.

A dissenting shareholder may not withdraw a Dissent Notice without the consent of the Company. A dissenting shareholder may, with the written consent of the Company, at any time prior to the payment to the dissenting shareholder of the full amount of money to which the dissenting shareholder is entitled, abandon such dissenting shareholder’s dissent to the Continuance by giving written notice to the Company withdrawing the Dissent Notice, by depositing such notice with the

Company, or mailing it to the Company by registered mail, at 12 Greenway Plaza, Suite 1100, Houston, Texas 77046, marked to the attention of the Corporate Secretary.

PROPOSAL 6

Authorizing the Directors to Determine the Number of Directors

The Board presently consists of six (6) directors and is seeking to elect five (5) directors at the Meeting. If the Continuance is effected, it is proposed that the directors be empowered to determine from time to time the number of directors of the Company, to be approved by way of a special resolution of Shareholders. The Directors currently have this ability under the Articles.

Special Resolution

Shareholders will be asked at the Meeting to consider, and, if thought appropriate, to pass, with or without variation, the following special resolution:

“BE IT HEREBY RESOLVED as a special resolution of International Battery Metals Ltd. (the “Company”) that, pursuant to section 125(3) of the Business Corporations Act (“Ontario”) (the “OBCA”), the directors of the Company are hereby empowered to determine from time to time by resolution the number of directors of the Company and the number of directors of the Company to be elected at annual meetings of the Shareholders of the Company.”

Required Vote and Board Recommendation

To be effective, Proposal 6 must be passed by two-thirds (66 2/3%) of the votes cast. Unless otherwise directed, management intends to vote such proxies in favor of the resolution approving Proposal 6.

The Board has reviewed the terms of Proposal 6 and concluded that it is in the best interests of the Company to proceed with Proposal 6. The Board recommends that the shareholders vote “FOR” Proposal 6.

PROPOSAL 7

APPOINTMENT OF AUDITORS AND RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Audit Committee has selected Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027. Shareholders will be asked to appoint Grant Thornton LLP as auditors of the Company to hold office until the close of the next annual meeting of shareholders and to authorize the directors to fix the remuneration of the auditors. In addition, management is submitting the selection of Grant Thornton LLP to the shareholders for ratification as a matter of good corporate practice. Grant Thornton LLP has never audited the Company’s financial statements. Representatives of Grant Thornton LLP are not expected to be present at the Annual Meeting and will not have an opportunity to respond to questions from the shareholders.

On June 24, 2026, the Audit Committee approved the engagement of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2027, replacing CBIZ CPAs P.C. (formerly Marcum LLP), which served as the Company's independent registered public accounting firm for the fiscal years ended March 31, 2025 and 2024. The decision to change the Company's independent registered public accounting firm was not the result of any disagreement between the Company and CBIZ CPAs P.C. on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure. The reports of CBIZ CPAs P.C. on the Company's financial statements for the fiscal years ended March 31, 2026 and 2025 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles, except that such reports contained an explanatory paragraph regarding the Company's ability to continue as a going concern. During the fiscal years ended March 31, 2026 and 2025 and through the date of CBIZ CPAs P.C.'s dismissal, there were no "disagreements" (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K) between the Company and CBIZ CPAs P.C. on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of CBIZ CPAs P.C., would have caused CBIZ CPAs P.C. to make reference to the subject matter of the disagreement in connection with its reports on the Company's financial statements.

Under applicable Canadian corporate law, the shareholders of the Company appoint the auditors at each annual meeting of shareholders and authorize the directors to fix the auditors' remuneration. While neither the Company’s Articles nor U.S. law require shareholder ratification of the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm, the Audit Committee is also submitting the selection to the shareholders for ratification as a matter of good corporate practice. If the shareholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in the best interests of the Company and its shareholders.

Audit Committee Oversight

At no time since the commencement of the Company's most recently completed financial year was a recommendation by the Audit Committee to nominate or compensate external auditors not adopted by the Board. The Audit Committee has reviewed the nature and amount of the non-audited services provided by CBIZ CPAs P.C., (formerly Marcum LLP) to the Company to ensure auditor independence.

Reliance on Certain Exemptions

During the most recently completed financial year, the Company has not relied on the exemptions contained in sections 2.4 or 8 of National Instrument 52-110 - Audit Committees (“NI 52-110”).

Section 2.4 provides an exemption from the requirement that the Audit Committee must pre-approve all non-audit services to be provided by the auditor, where the total amount of all the non-audit services not pre-approved is reasonably expected to be no more than 5% of the total fees payable to the auditors in the fiscal year in which the non-audit services were provided, the Company did not recognize the services as non-audit services at the time of engagement, and the services are promptly brought to the attention of the Audit Committee and approved prior to the completion of the audit by the Audit Committee.

Section 8 permits a company to apply to a securities regulatory authority for an exemption from the requirements of NI 52-110 in whole or in part.

Audit, Audit-Related, Tax, and Other Fees

The following table sets forth the aggregate fees billed or expected to be billed by CBIZ CPAs P.C. (formally Marcum LLP), for professional services rendered in connection with the fiscal years ended March 31, 2026 and 2025.